JPH0141609B2 - - Google Patents
Info
- Publication number
- JPH0141609B2 JPH0141609B2 JP55183671A JP18367180A JPH0141609B2 JP H0141609 B2 JPH0141609 B2 JP H0141609B2 JP 55183671 A JP55183671 A JP 55183671A JP 18367180 A JP18367180 A JP 18367180A JP H0141609 B2 JPH0141609 B2 JP H0141609B2
- Authority
- JP
- Japan
- Prior art keywords
- tylosin
- apramycin
- combination
- physiologically acceptable
- antibiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229950006334 apramycin Drugs 0.000 claims description 53
- 229930194936 Tylosin Natural products 0.000 claims description 42
- 235000019375 tylosin Nutrition 0.000 claims description 42
- 239000004182 Tylosin Substances 0.000 claims description 41
- 229960004059 tylosin Drugs 0.000 claims description 41
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 claims description 41
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 claims description 37
- 241000204031 Mycoplasma Species 0.000 claims description 33
- 241000282887 Suidae Species 0.000 claims description 33
- 229960000707 tobramycin Drugs 0.000 claims description 31
- 150000003839 salts Chemical class 0.000 claims description 29
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 239000003120 macrolide antibiotic agent Substances 0.000 claims description 15
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 claims description 14
- 229960002518 gentamicin Drugs 0.000 claims description 10
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 9
- 229930182566 Gentamicin Natural products 0.000 claims description 9
- 229940126574 aminoglycoside antibiotic Drugs 0.000 claims description 9
- IEMDOFXTVAPVLX-YWQHLDGFSA-N Leucomycin A1 Chemical compound CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](OC(=O)CC(C)C)[C@](C)(O)C2)[C@@H](C)O1 IEMDOFXTVAPVLX-YWQHLDGFSA-N 0.000 claims description 8
- 230000000844 anti-bacterial effect Effects 0.000 claims description 8
- 229930193140 Neomycin Natural products 0.000 claims description 7
- FQVHOULQCKDUCY-OGHXVOSASA-N [(2s,3s,4r,6s)-6-[(2r,3s,4r,5r,6s)-6-[[(1s,3r,7r,8s,9s,10r,12r,14e,16s)-7-acetyloxy-8-methoxy-3,12-dimethyl-5,13-dioxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-9-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimeth Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@H]1[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/[C@@H]2O[C@H]2C[C@@H](C)OC(=O)C[C@H]([C@@H]1OC)OC(C)=O)[C@H]1C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O1 FQVHOULQCKDUCY-OGHXVOSASA-N 0.000 claims description 7
- 229960004927 neomycin Drugs 0.000 claims description 7
- 239000004104 Oleandomycin Substances 0.000 claims description 6
- RZPAKFUAFGMUPI-UHFFFAOYSA-N Oleandomycin Natural products O1C(C)C(O)C(OC)CC1OC1C(C)C(=O)OC(C)C(C)C(O)C(C)C(=O)C2(OC2)CC(C)C(OC2C(C(CC(C)O2)N(C)C)O)C1C RZPAKFUAFGMUPI-UHFFFAOYSA-N 0.000 claims description 6
- RZPAKFUAFGMUPI-KGIGTXTPSA-N oleandomycin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RZPAKFUAFGMUPI-KGIGTXTPSA-N 0.000 claims description 6
- 235000019367 oleandomycin Nutrition 0.000 claims description 6
- 229960002351 oleandomycin Drugs 0.000 claims description 6
- 235000021050 feed intake Nutrition 0.000 claims description 5
- NBOODGNJLRRJNA-IAGPQMRQSA-N 2-[(4r,5s,6s,7r,9r,11e,13e,15r,16r)-6-[(2r,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2r,3r,4r,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl Chemical compound OP(O)(O)=O.O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 NBOODGNJLRRJNA-IAGPQMRQSA-N 0.000 claims description 4
- 229950011272 nebramycin Drugs 0.000 claims description 4
- 229940031989 tylosin phosphate Drugs 0.000 claims description 4
- SKKLOUVUUNMCJE-FQSMHNGLSA-N kanamycin B Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SKKLOUVUUNMCJE-FQSMHNGLSA-N 0.000 claims description 3
- 229930182824 kanamycin B Natural products 0.000 claims description 3
- WGLYHYWDYPSNPF-RQFIXDHTSA-N Apramycin sulfate Chemical compound OS(O)(=O)=O.O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O WGLYHYWDYPSNPF-RQFIXDHTSA-N 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 description 40
- 239000003242 anti bacterial agent Substances 0.000 description 37
- 229940088710 antibiotic agent Drugs 0.000 description 36
- 239000002609 medium Substances 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000011109 contamination Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 230000002195 synergetic effect Effects 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 235000019786 weight gain Nutrition 0.000 description 6
- 230000004584 weight gain Effects 0.000 description 6
- 241000202938 Mycoplasma hyorhinis Species 0.000 description 5
- 241000282898 Sus scrofa Species 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 239000012984 antibiotic solution Substances 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 241000282693 Cercopithecidae Species 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940126575 aminoglycoside Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000003292 kidney cell Anatomy 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011885 synergistic combination Substances 0.000 description 3
- 229940095064 tartrate Drugs 0.000 description 3
- 239000003104 tissue culture media Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 241001430197 Mollicutes Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 229940000425 combination drug Drugs 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- ICVKYYINQHWDLM-KBEWXLTPSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;2-[(4r,5s,6s,7r,9r,11e,13e,15r,16r)-6-[(2r,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2r,3r,4r,5r,6r)-5-hydroxy-3,4 Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 ICVKYYINQHWDLM-KBEWXLTPSA-N 0.000 description 1
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- ZEUUPKVZFKBXPW-TWDWGCDDSA-N (2s,3r,4s,5s,6r)-4-amino-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N ZEUUPKVZFKBXPW-TWDWGCDDSA-N 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- OLLVTRJWJCUNEY-IAGPQMRQSA-N 2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde hydrochloride Chemical compound Cl.CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC OLLVTRJWJCUNEY-IAGPQMRQSA-N 0.000 description 1
- JHNLZOVBAQWGQU-UHFFFAOYSA-N 380814_sial Chemical compound CS(O)(=O)=O.O=P(=O)OP(=O)=O JHNLZOVBAQWGQU-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001293418 Mannheimia haemolytica Species 0.000 description 1
- 241000204022 Mycoplasma gallisepticum Species 0.000 description 1
- 241000204003 Mycoplasmatales Species 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000021051 daily weight gain Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229940053050 neomycin sulfate Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229960004477 tobramycin sulfate Drugs 0.000 description 1
- 229960001717 tylosin tartrate Drugs 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
Description
æ¬çºæã¯ããã¯ãã©ã€ãæçç©è³ªãšã¢ããã°ãª
ã³ã·ãæçç©è³ªãšãããªãæ°èŠæçç©è³ªåå€ïŒæ
èçµæç©ïŒã«é¢ããããã®åå€ã¯ãæ®ã«è±ã®å€§è ž
èçïŒcolibacillosisïŒã®æ²»çã«æå¹ã§ããããŸ
ããã®çš®ã®åç©ã®æé·ä¿é²å€ãšããŠãããã«é£Œæ
æåã®æ¹åã«æçšã§ããããšãèŠåºãããŠããã
ãŸãããã®åå€ã¯ãåºä¹³åç©ã®çµç¹å¹é€ã«ãããŠ
ãã€ã³ãã©ãºãã®çè²ãæå¶ããã ãã®åå€ã圢æãããã¯ãã©ã€ãæçç©è³ªãã
ã³ã¢ããã°ãªã³ã·ãæçç©è³ªã¯ããã¹ãŠæ¢ç¥ã§ã
ããã¿ã€ãã·ã³ïŒtylosinïŒã¯ç±³åœç¹èš±3178341ã
ãã³ã¡ã«ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒNo.9486ã«èšèŒ
ãããŠãããåç©çšæçç©è³ªãšããŠåžè²©ãããŠã
ããã¹ãããã€ã·ã³ïŒspiromycinïŒã¯ç±³åœç¹èš±
2943023ããã³ã¡ã«ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒNo.
8525ã«èšèŒãããŠããããã€ã³ãã€ã·ã³
ïŒleucomycinïŒã¯ã¡ã«ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒ
No.5307ã«èšèŒãããŠããããã°ããã€ã·ã³
ïŒmagnamycinïŒã¯ç±³åœç¹èš±2960438ããã³ã¡ã«
ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒNo.1812ã«èšèŒãããŠã
ãããªã¬ã¢ã³ããã€ã·ã³ïŒoleandomycinïŒã¯ç±³
åœç¹èš±2757123ããã³å2842481ãªãã³ã«ã¡ã«ã¯ã»
ã€ã³ããã¯ã¹ïŒïŒçïŒNo.6671ã«èšèŒãããŠããã ã¢ããã°ãªã³ã·ãæçç©è³ªã§ããããã©ãã€ã·
ã³ïŒtobramycinïŒããã³ã¢ãã©ãã€ã·ã³
ïŒapramycinïŒã¯ãããããããã©ãã€ã·ã³
ïŒnebramycinïŒå åïŒããã³ïŒãšããå¥å称ã§ã
ç¥ãããŠãããããã©ãã€ã·ã³ãã¢ãã©ãã€ã·ã³
ããã³ããã©ãã€ã·ã³å åïŒã¯ãStreptomyces
tennibrariusã«ãã€ãŠçç£ãããããã©ãã€ã·ã³
è€åäœã®æ§æã åã§ãããç±³åœç¹èš±3691279ã«èš
èŒãããŠãããããã©ãã€ã·ã³ã¯ãããã«å¯Ÿãã
å»è¬ãšããŠèšåºäžå®çšã«äŸãããŠãããããªãã€
ã·ã³ïŒneomycinïŒã¯ç±³åœç¹èš±2799620ã«èšèŒãã
ãŠãããã²ã³ã¿ãã€ã·ã³ïŒgentamycinïŒã¯ç±³åœ
ç¹èš±3091572ããã³ã¡ã«ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒ
No.4233ã«èšèŒãããŠããã æ¬çºæã«ãã€ãŠæäŸãããæçç©è³ªåå€ã¯ã(a)
ã¿ã€ãã·ã³ããã€ã³ãã€ã·ã³ããã°ããã€ã·ã³ã
ã¹ãããã€ã·ã³ããã³ãªã¬ã¢ã³ããã€ã·ã³ãªãã³
ã«çççã«èš±å®¹ããããããã®å¡©ããéžãã°ãã
ãã¯ãã©ã€ãæçç©è³ªãšã(b)ããã©ãã€ã·ã³ãã¢
ãã©ãã€ã·ã³ãããã©ãã€ã·ã³å åïŒãã²ã³ã¿ã
ã€ã·ã³ããã³ããªãã€ã·ã³ãªãã³ã«çççã«èš±å®¹
ããããããã®å¡©ããéžãã°ããã¢ããã°ãªã³ã·
ããšãå«æããã æ¬çºæã¯ãŸããäžèšã®æçç©è³ªåå€ãè±ã«æäž
ããããšã«ãã€ãŠããã®æé·ãŸãã¯é£Œææåãä¿
é²ããæ¹æ³ãæäŸããã æ¬çºæã¯ãŸããäžèšã®æçç©è³ªåå€ã§åºä¹³é¡ã®
å¹é€çµç¹ãåŠçããããšã«ãã€ãŠãçµç¹äžã§ã®ã
ã€ã³ãã©ãºãã®çè²ãæå¶ããæ¹æ³ãæäŸããã æ¬çºæã¯ãŸããäžèšã®æçç©è³ªåå€ãè±ã«æäž
ããããšãããªãè±ã®å€§è žèçã®æ²»çæ¹æ³ãæäŸ
ããã æ¬çºæã®æçç©è³ªåå€ã¯ããã€ã³ãã©ãºãã®æ
å¶ã«æçšã§ãããæ®ã«åã ã®æçç©è³ªã«èæ§ãæ
ãããã€ã³ãã©ãºãã®å Žåã«æçšã§ãããæ¬åå€
ã®çžä¹å¹æïŒsynergismïŒã¯ããã€ã³ãã©ãºãã«
ããæ±æãé »ç¹ã«èµ·ãåºä¹³åç©ã®çµç¹å¹é€ã§èšŒæ
ããããçš®ã ã®çŽ°èç³»åã®çµç¹å¹é€ïŒããšãã°ã
åç©ãŠã€ã«ã¹ã®å¢æ®ãè¡ãå ŽåïŒã«ããããã€ã³
ãã©ãºãæ±æã¯ãå Žåã«ãã€ãŠã¯æ°é±éãå¹é€ã
è¡ã€ãåŸã«ãçµç¹å¹é€ç©ãé§ç®ã«ããŠããŸãããš
ããããæ¬çºæåå€ã®çžä¹æŽ»æ§ã¯ãåºä¹³åç©ã®çµ
ç¹å¹é€ã«ãããèæ§ãã€ã³ãã©ãºãã«å¯ŸããŠãæ
ããã瀺ããããããã§âèæ§ãã€ã³ãã©ãºãâ
ãšããçšèªã¯ãæ¬çºæåå€ã«å«ãŸãããã¯ãã©ã€
ãæçç©è³ªããã³ã¢ããã°ãªã³ã·ãæçç©è³ªã®çž
æ¹ã«å¯ŸããŠããããã®æçç©è³ªãçš®ã ã®åŸ®çç©ã«
察ããŠäžè¬ã«ç€ºãMICïŒæå°çºè²é»æ¢æ¿åºŠïŒãã
é«ãæ¿åºŠã«ãããŠèæ§ã§ãããã€ã³ãã©ãºããæ
å³ãããå€ãã®ãã€ã³ãã©ãºããæ¬çºæåå€ã«å«
ãŸããæçç©è³ªã«èæ§ã§ãããåºä¹³åç©ã®çµç¹å¹
é€ã«ãããæ±ææºãšãªãèæ§ãã€ã³ãã©ãºãã§äž»
èŠãªã®ã¯ãã€ã³ãã©ãºãã»ããšãªãã¹ïŒM.
hyorhinisïŒã«å±ããæ ªã§ããããã€ã³ãã©ãº
ãã»ã¬ãªã»ããã€ã¯ã ïŒM.gallisepticumïŒã®è
æ§æ ªããŸãé »åºŠã®å€ãæ±æèã§ãããæ¬çºæã®çž
ä¹çåå€ã¯ãåã ã®æçç©è³ªãåç¬ã§ã¯é«æ¿åºŠã§
ç¡å¹ã§ããèæ§ãã€ã³ãã©ãºãã®çè²ãäœæ¿åºŠã§
é»æ¢ããã次ã«ç€ºãè¡šïŒã¯ãåã ã®ãã¯ãã©ã€ã
æçç©è³ªããã³ã¢ããã°ãªã³ã·ãæçç©è³ªãªãã³
ã«ãããã®åå€ã®æå°çºè²é»æ¢æ¿åºŠïŒMICïŒ
mcgïŒmlïŒã瀺ããMICå€ã¯ãåãã€ã³ãã©ãºã
ã§æ±æãããåºä¹³åç©ã®å¹é€çµç¹ãçšããäžèšã®
å®éšæ¹æ³ã«ãã€ãŠåŸãã ç¿è 现èLLCâMK2ãå¹å°199ïŒMorgan et
alïŒProc.Soc.Exp.Bio.Med.ïŒ73ïŒïŒïŒ1950ïŒïŒã«
æžæ¿ããããã«åãã€ã³ãã©ãºããæ¥çš®çŽ°èæ°æ¿
床ã1.5Ã107åïŒmlãšãªãããã«æ¥çš®ãããåè©Š
éšã«ã€ããŠã³ã³ãããŒã«å¹å°ãšãã€ã³ãã©ãºãéœ
æ§å¹å°ãšãçšãã37âã§ïŒâïŒæ¥éå¹é€ãã次ã
ã§ãã¹ãŠã®å¹é€ç©ã®å¹å°ããéçé žãããªãŠã
1.68ïœïŒãå«ãå¹å°199äžã«ïŒïŒ ã®éŠ¬è¡æž ãå
ãããã®ã«å€ããããã€ã³ãã©ãºããæ¥çš®ããçµ
ç¹å¹é€ç©ïŒãã€ã³ãã©ãºãéœæ§ã³ã³ãããŒã«å¹é€
ç©ãé€ãïŒãè¡šïŒã«ç€ºãããã«åæçç©è³ªåç¬ã
ãã³åå€ã§åŠçãããæçç©è³ªã®åå€ãè©Šéšãã
å Žåãç¹éã®æçç©è³ªãçšããã æçç©è³ªã®æº¶æ¶²ã¯ãéçé žãããªãŠã 1.68ïœïŒ
ãå«ãå¹å°199ãçšããŠèª¿è£œããããã®æº¶æ¶²ã
ããªãã¢çŽïŒporosityïŒ0.2ÎŒïŒãéããŠæ» è
éãã䜿çšæãŸã§ïŒâã§è²¯èµãããæçç©è³ªæº¶æ¶²
ãåæ°çšéããå溶液ãå¥ã ã®å¹é€ç©ã«å ããŠæ
å°çºè²é»æ¢æ¿åºŠã決å®ãããåå¹é€ç©ã®å¹å°ã¯é±
ã«ïŒå亀æãããã®éœåºŠæ°ãã«æçç©è³ªæº¶æ¶²ãå
äžæ¿åºŠãšãªãããã«å ãããïŒé±éåŸãå¹å°äº€æ
ãæçç©è³ªæãã§ããã«ïŒé±éè¡ã€ããæçµã®ïŒ
é±éãå¹å°äº€æã®åºŠã«å¹é€ç©ã®ãµã³ãã«ãäºãå
ãããã€ã³ãã©ãºãã®ååšãæ€å®ããããã«å¹é€
ããã
ã³ã·ãæçç©è³ªãšãããªãæ°èŠæçç©è³ªåå€ïŒæ
èçµæç©ïŒã«é¢ããããã®åå€ã¯ãæ®ã«è±ã®å€§è ž
èçïŒcolibacillosisïŒã®æ²»çã«æå¹ã§ããããŸ
ããã®çš®ã®åç©ã®æé·ä¿é²å€ãšããŠãããã«é£Œæ
æåã®æ¹åã«æçšã§ããããšãèŠåºãããŠããã
ãŸãããã®åå€ã¯ãåºä¹³åç©ã®çµç¹å¹é€ã«ãããŠ
ãã€ã³ãã©ãºãã®çè²ãæå¶ããã ãã®åå€ã圢æãããã¯ãã©ã€ãæçç©è³ªãã
ã³ã¢ããã°ãªã³ã·ãæçç©è³ªã¯ããã¹ãŠæ¢ç¥ã§ã
ããã¿ã€ãã·ã³ïŒtylosinïŒã¯ç±³åœç¹èš±3178341ã
ãã³ã¡ã«ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒNo.9486ã«èšèŒ
ãããŠãããåç©çšæçç©è³ªãšããŠåžè²©ãããŠã
ããã¹ãããã€ã·ã³ïŒspiromycinïŒã¯ç±³åœç¹èš±
2943023ããã³ã¡ã«ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒNo.
8525ã«èšèŒãããŠããããã€ã³ãã€ã·ã³
ïŒleucomycinïŒã¯ã¡ã«ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒ
No.5307ã«èšèŒãããŠããããã°ããã€ã·ã³
ïŒmagnamycinïŒã¯ç±³åœç¹èš±2960438ããã³ã¡ã«
ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒNo.1812ã«èšèŒãããŠã
ãããªã¬ã¢ã³ããã€ã·ã³ïŒoleandomycinïŒã¯ç±³
åœç¹èš±2757123ããã³å2842481ãªãã³ã«ã¡ã«ã¯ã»
ã€ã³ããã¯ã¹ïŒïŒçïŒNo.6671ã«èšèŒãããŠããã ã¢ããã°ãªã³ã·ãæçç©è³ªã§ããããã©ãã€ã·
ã³ïŒtobramycinïŒããã³ã¢ãã©ãã€ã·ã³
ïŒapramycinïŒã¯ãããããããã©ãã€ã·ã³
ïŒnebramycinïŒå åïŒããã³ïŒãšããå¥å称ã§ã
ç¥ãããŠãããããã©ãã€ã·ã³ãã¢ãã©ãã€ã·ã³
ããã³ããã©ãã€ã·ã³å åïŒã¯ãStreptomyces
tennibrariusã«ãã€ãŠçç£ãããããã©ãã€ã·ã³
è€åäœã®æ§æã åã§ãããç±³åœç¹èš±3691279ã«èš
èŒãããŠãããããã©ãã€ã·ã³ã¯ãããã«å¯Ÿãã
å»è¬ãšããŠèšåºäžå®çšã«äŸãããŠãããããªãã€
ã·ã³ïŒneomycinïŒã¯ç±³åœç¹èš±2799620ã«èšèŒãã
ãŠãããã²ã³ã¿ãã€ã·ã³ïŒgentamycinïŒã¯ç±³åœ
ç¹èš±3091572ããã³ã¡ã«ã¯ã»ã€ã³ããã¯ã¹ïŒïŒçïŒ
No.4233ã«èšèŒãããŠããã æ¬çºæã«ãã€ãŠæäŸãããæçç©è³ªåå€ã¯ã(a)
ã¿ã€ãã·ã³ããã€ã³ãã€ã·ã³ããã°ããã€ã·ã³ã
ã¹ãããã€ã·ã³ããã³ãªã¬ã¢ã³ããã€ã·ã³ãªãã³
ã«çççã«èš±å®¹ããããããã®å¡©ããéžãã°ãã
ãã¯ãã©ã€ãæçç©è³ªãšã(b)ããã©ãã€ã·ã³ãã¢
ãã©ãã€ã·ã³ãããã©ãã€ã·ã³å åïŒãã²ã³ã¿ã
ã€ã·ã³ããã³ããªãã€ã·ã³ãªãã³ã«çççã«èš±å®¹
ããããããã®å¡©ããéžãã°ããã¢ããã°ãªã³ã·
ããšãå«æããã æ¬çºæã¯ãŸããäžèšã®æçç©è³ªåå€ãè±ã«æäž
ããããšã«ãã€ãŠããã®æé·ãŸãã¯é£Œææåãä¿
é²ããæ¹æ³ãæäŸããã æ¬çºæã¯ãŸããäžèšã®æçç©è³ªåå€ã§åºä¹³é¡ã®
å¹é€çµç¹ãåŠçããããšã«ãã€ãŠãçµç¹äžã§ã®ã
ã€ã³ãã©ãºãã®çè²ãæå¶ããæ¹æ³ãæäŸããã æ¬çºæã¯ãŸããäžèšã®æçç©è³ªåå€ãè±ã«æäž
ããããšãããªãè±ã®å€§è žèçã®æ²»çæ¹æ³ãæäŸ
ããã æ¬çºæã®æçç©è³ªåå€ã¯ããã€ã³ãã©ãºãã®æ
å¶ã«æçšã§ãããæ®ã«åã ã®æçç©è³ªã«èæ§ãæ
ãããã€ã³ãã©ãºãã®å Žåã«æçšã§ãããæ¬åå€
ã®çžä¹å¹æïŒsynergismïŒã¯ããã€ã³ãã©ãºãã«
ããæ±æãé »ç¹ã«èµ·ãåºä¹³åç©ã®çµç¹å¹é€ã§èšŒæ
ããããçš®ã ã®çŽ°èç³»åã®çµç¹å¹é€ïŒããšãã°ã
åç©ãŠã€ã«ã¹ã®å¢æ®ãè¡ãå ŽåïŒã«ããããã€ã³
ãã©ãºãæ±æã¯ãå Žåã«ãã€ãŠã¯æ°é±éãå¹é€ã
è¡ã€ãåŸã«ãçµç¹å¹é€ç©ãé§ç®ã«ããŠããŸãããš
ããããæ¬çºæåå€ã®çžä¹æŽ»æ§ã¯ãåºä¹³åç©ã®çµ
ç¹å¹é€ã«ãããèæ§ãã€ã³ãã©ãºãã«å¯ŸããŠãæ
ããã瀺ããããããã§âèæ§ãã€ã³ãã©ãºãâ
ãšããçšèªã¯ãæ¬çºæåå€ã«å«ãŸãããã¯ãã©ã€
ãæçç©è³ªããã³ã¢ããã°ãªã³ã·ãæçç©è³ªã®çž
æ¹ã«å¯ŸããŠããããã®æçç©è³ªãçš®ã ã®åŸ®çç©ã«
察ããŠäžè¬ã«ç€ºãMICïŒæå°çºè²é»æ¢æ¿åºŠïŒãã
é«ãæ¿åºŠã«ãããŠèæ§ã§ãããã€ã³ãã©ãºããæ
å³ãããå€ãã®ãã€ã³ãã©ãºããæ¬çºæåå€ã«å«
ãŸããæçç©è³ªã«èæ§ã§ãããåºä¹³åç©ã®çµç¹å¹
é€ã«ãããæ±ææºãšãªãèæ§ãã€ã³ãã©ãºãã§äž»
èŠãªã®ã¯ãã€ã³ãã©ãºãã»ããšãªãã¹ïŒM.
hyorhinisïŒã«å±ããæ ªã§ããããã€ã³ãã©ãº
ãã»ã¬ãªã»ããã€ã¯ã ïŒM.gallisepticumïŒã®è
æ§æ ªããŸãé »åºŠã®å€ãæ±æèã§ãããæ¬çºæã®çž
ä¹çåå€ã¯ãåã ã®æçç©è³ªãåç¬ã§ã¯é«æ¿åºŠã§
ç¡å¹ã§ããèæ§ãã€ã³ãã©ãºãã®çè²ãäœæ¿åºŠã§
é»æ¢ããã次ã«ç€ºãè¡šïŒã¯ãåã ã®ãã¯ãã©ã€ã
æçç©è³ªããã³ã¢ããã°ãªã³ã·ãæçç©è³ªãªãã³
ã«ãããã®åå€ã®æå°çºè²é»æ¢æ¿åºŠïŒMICïŒ
mcgïŒmlïŒã瀺ããMICå€ã¯ãåãã€ã³ãã©ãºã
ã§æ±æãããåºä¹³åç©ã®å¹é€çµç¹ãçšããäžèšã®
å®éšæ¹æ³ã«ãã€ãŠåŸãã ç¿è 现èLLCâMK2ãå¹å°199ïŒMorgan et
alïŒProc.Soc.Exp.Bio.Med.ïŒ73ïŒïŒïŒ1950ïŒïŒã«
æžæ¿ããããã«åãã€ã³ãã©ãºããæ¥çš®çŽ°èæ°æ¿
床ã1.5Ã107åïŒmlãšãªãããã«æ¥çš®ãããåè©Š
éšã«ã€ããŠã³ã³ãããŒã«å¹å°ãšãã€ã³ãã©ãºãéœ
æ§å¹å°ãšãçšãã37âã§ïŒâïŒæ¥éå¹é€ãã次ã
ã§ãã¹ãŠã®å¹é€ç©ã®å¹å°ããéçé žãããªãŠã
1.68ïœïŒãå«ãå¹å°199äžã«ïŒïŒ ã®éŠ¬è¡æž ãå
ãããã®ã«å€ããããã€ã³ãã©ãºããæ¥çš®ããçµ
ç¹å¹é€ç©ïŒãã€ã³ãã©ãºãéœæ§ã³ã³ãããŒã«å¹é€
ç©ãé€ãïŒãè¡šïŒã«ç€ºãããã«åæçç©è³ªåç¬ã
ãã³åå€ã§åŠçãããæçç©è³ªã®åå€ãè©Šéšãã
å Žåãç¹éã®æçç©è³ªãçšããã æçç©è³ªã®æº¶æ¶²ã¯ãéçé žãããªãŠã 1.68ïœïŒ
ãå«ãå¹å°199ãçšããŠèª¿è£œããããã®æº¶æ¶²ã
ããªãã¢çŽïŒporosityïŒ0.2ÎŒïŒãéããŠæ» è
éãã䜿çšæãŸã§ïŒâã§è²¯èµãããæçç©è³ªæº¶æ¶²
ãåæ°çšéããå溶液ãå¥ã ã®å¹é€ç©ã«å ããŠæ
å°çºè²é»æ¢æ¿åºŠã決å®ãããåå¹é€ç©ã®å¹å°ã¯é±
ã«ïŒå亀æãããã®éœåºŠæ°ãã«æçç©è³ªæº¶æ¶²ãå
äžæ¿åºŠãšãªãããã«å ãããïŒé±éåŸãå¹å°äº€æ
ãæçç©è³ªæãã§ããã«ïŒé±éè¡ã€ããæçµã®ïŒ
é±éãå¹å°äº€æã®åºŠã«å¹é€ç©ã®ãµã³ãã«ãäºãå
ãããã€ã³ãã©ãºãã®ååšãæ€å®ããããã«å¹é€
ããã
ãè¡šã
ãè¡šã
ã€ã·ã³
ãè¡šã
è¡šïŒã«ç€ºãããŠããããã«ãè©Šéšã«äŸãããã€
ã³ãã©ãºãã¯ãåã ã®æçç©è³ªã®å Žåãé«æ¿åºŠã«
ãããŠã®ã¿æå¶ããããããããªãããæ¬çºæã®
ãã¯ãã©ã€ãâã¢ããã°ãªã³ã·ãåå€ãçšããå Ž
åã¯ãé¥ãã«äœæ¿åºŠã§ãããã®ãã€ã³ãã©ãºãã
æå¶ãããååå€ã§ã¯ãåã ã®æçç©è³ªã¯çéã
ã€äœ¿çšããã æ¬çºæã®åå€ã¯ãåºä¹³åç©çµç¹ã«å¯ŸããŠç¡æ¯æ§
ã§ããã现èç³»ïŒcell linesïŒããã€ã³ãã©ãºã
æ±æãªãã«ä¿åããããã«äœ¿çšããåŸããæ¬åå€
ã¯ãŸããéåžžå¹é€çµç¹ã®çŽ°èæ±æãé²æ¢ãããã
ã«äœ¿çšãããä»ã®æçç©è³ªïŒãã ãããã€ã³ãã©
ãºãã®æå¶ã«ã¯å¹æããªãïŒãšçµåããŠäœ¿çšãã
ããšãã§ãããããšãã°ããã®çžä¹çåå€ã¯ãçµ
ç¹å¹é€ã§äžè¬ã«çšããããããã·ãªã³ïŒããšã
ã°ãããã·ãªã³ïŒ§ïŒãã¹ãã¬ãããã€ã·ã³ãšå ±ã«
䜿çšããåŸãã æ¬çºæã®å¥œãŸããåå€ã¯ã¿ã€ãã·ã³âããã©ã
ã€ã·ã³ã§ããããã®çµåãã¯ãã¿ã€ãã·ã³ããã³
ããã©ãã€ã·ã³ãåç¬ã§ã¯é«æ¿åºŠã«ãããŠã®ã¿äœ
çšãããã€ã³ãã©ãºãã«å¯ŸããŠãäžè²«ããŠäœãæ
å°çºè²é»æ¢æ¿åºŠã瀺ããã次ã«æ²ããè¡šïŒã¯ãç¿
è 现èLLCâMK2ãçšããçµç¹å¹é€ãããŠM.
hyorhinisã®çè²ãé»æ¢ããçš®ã ã®ã¿ã€ãã·ã³â
ããã©ãã€ã·ã³åå€ãçšããŠåŸãçµæã瀺ããã
ã®è©Šéšã¯æ¬¡ã®ããã«ããŠå®æœããã LLCâMK2现èã«å¯Ÿããã¿ã€ãã·ã³âããã©
ãã€ã·ã³åå€ãæ·»å ããïŒæ¥åã«M.hyorhinisã
æ¥çš®ããäž¡æçç©è³ªãçš®ã ã®æ··åæ¯ã§ããã€æ¿åºŠ
ãå€ããŠäœ¿çšãããå¹å°ã®äº€æã¯ãïŒâïŒæ¥æ¯ã«
è¡ãããã®éœåºŠæçç©è³ªãå ãããå¹å°äº€æã®åºŠ
ã«å¹é€å¹å°ã®ãµã³ãã«ãåãããã€ã³ãã©ãºãã®
æ€å®ãè¡ã€ããè¡šïŒã®æ°å€ã¯ãM.hyorhinisã®ç
è²ãé»æ¢ããåå€ã«ãããæçç©è³ªã®æ··åå²åã
瀺ããŠããã
ã³ãã©ãºãã¯ãåã ã®æçç©è³ªã®å Žåãé«æ¿åºŠã«
ãããŠã®ã¿æå¶ããããããããªãããæ¬çºæã®
ãã¯ãã©ã€ãâã¢ããã°ãªã³ã·ãåå€ãçšããå Ž
åã¯ãé¥ãã«äœæ¿åºŠã§ãããã®ãã€ã³ãã©ãºãã
æå¶ãããååå€ã§ã¯ãåã ã®æçç©è³ªã¯çéã
ã€äœ¿çšããã æ¬çºæã®åå€ã¯ãåºä¹³åç©çµç¹ã«å¯ŸããŠç¡æ¯æ§
ã§ããã现èç³»ïŒcell linesïŒããã€ã³ãã©ãºã
æ±æãªãã«ä¿åããããã«äœ¿çšããåŸããæ¬åå€
ã¯ãŸããéåžžå¹é€çµç¹ã®çŽ°èæ±æãé²æ¢ãããã
ã«äœ¿çšãããä»ã®æçç©è³ªïŒãã ãããã€ã³ãã©
ãºãã®æå¶ã«ã¯å¹æããªãïŒãšçµåããŠäœ¿çšãã
ããšãã§ãããããšãã°ããã®çžä¹çåå€ã¯ãçµ
ç¹å¹é€ã§äžè¬ã«çšããããããã·ãªã³ïŒããšã
ã°ãããã·ãªã³ïŒ§ïŒãã¹ãã¬ãããã€ã·ã³ãšå ±ã«
䜿çšããåŸãã æ¬çºæã®å¥œãŸããåå€ã¯ã¿ã€ãã·ã³âããã©ã
ã€ã·ã³ã§ããããã®çµåãã¯ãã¿ã€ãã·ã³ããã³
ããã©ãã€ã·ã³ãåç¬ã§ã¯é«æ¿åºŠã«ãããŠã®ã¿äœ
çšãããã€ã³ãã©ãºãã«å¯ŸããŠãäžè²«ããŠäœãæ
å°çºè²é»æ¢æ¿åºŠã瀺ããã次ã«æ²ããè¡šïŒã¯ãç¿
è 现èLLCâMK2ãçšããçµç¹å¹é€ãããŠM.
hyorhinisã®çè²ãé»æ¢ããçš®ã ã®ã¿ã€ãã·ã³â
ããã©ãã€ã·ã³åå€ãçšããŠåŸãçµæã瀺ããã
ã®è©Šéšã¯æ¬¡ã®ããã«ããŠå®æœããã LLCâMK2现èã«å¯Ÿããã¿ã€ãã·ã³âããã©
ãã€ã·ã³åå€ãæ·»å ããïŒæ¥åã«M.hyorhinisã
æ¥çš®ããäž¡æçç©è³ªãçš®ã ã®æ··åæ¯ã§ããã€æ¿åºŠ
ãå€ããŠäœ¿çšãããå¹å°ã®äº€æã¯ãïŒâïŒæ¥æ¯ã«
è¡ãããã®éœåºŠæçç©è³ªãå ãããå¹å°äº€æã®åºŠ
ã«å¹é€å¹å°ã®ãµã³ãã«ãåãããã€ã³ãã©ãºãã®
æ€å®ãè¡ã€ããè¡šïŒã®æ°å€ã¯ãM.hyorhinisã®ç
è²ãé»æ¢ããåå€ã«ãããæçç©è³ªã®æ··åå²åã
瀺ããŠããã
ãè¡šã
è¡šïŒã«ç€ºãããã¹ãŠã®ã¿ã€ãã·ã³âããã©ãã€
ã·ã³åå€ã¯ã3.5é±éã«ããã€ãŠå®æœããïŒâïŒ
åã®ãµã³ããªã³ã°ã«ãããŠãã€ã³ãã©ãºãã®çè²
ãé»æ¢ãããåç¬äœ¿çšã®å Žåã¯ãã¿ã€ãã·ã³ãã
ãã©ãã€ã·ã³å ±ã«è¡šïŒã«ç€ºããããã«é¥ãã«é«ã
MICå€ã瀺ãã è¡šïŒã®æ°å€ã¯ãäœæ¿åºŠã§æ¬çºæã®æçç©è³ªåå€
ãçžä¹çã«æå¹ã§ããããšã瀺ããŠãããïŒéé
éšä»¥äžã®ããã©ãã€ã·ã³ã«å¯ŸããŠïŒéééšä»¥äžã®
ã¿ã€ãã·ã³ãå«ãåå€ã奜ãŸããçžä¹ççµæç©ã§
ããã æ¬çºæã®ãä»ã®å¥œãŸããåå€ã¯ããã©ãã€ã·ã³
ãšã¢ãã©ãã€ã·ã³ã®çµåãã§ãããè¡šïŒã«ç€ºãã
ãŠããããã«ãã¿ã€ãã·ã³12mcgïŒmlãšã¢ãã©ã
ã€ã·ã³12mcgïŒmlãå«ã溶液ã¯ãã€ã³ãã©ãºãã
é»æ¢ããããã¢ãã©ãã€ã·ã³åç¬ã®MICã¯
600mcgïŒmlã§ãããã¿ã€ãã·ã³ã®ããã¯
200mcgïŒmlã§ããã ä»ã®å¥œãŸããåå€ã¯ãã¿ã€ãã·ã³ãšã²ã³ã¿ãã€
ã·ã³ã®çµåãã§ããã æ¬çºæã®ãã¯ãã©ã€ãæçç©è³ªãšã¢ããã°ãªã³
ã·ãæçç©è³ªãšã®åå€ã§çžä¹äœçšã蚌æãããã®
ã«ããã¯ãã©ã€ãâãã¯ãã©ã€ãæçç©è³ªåå€ã®
å€ãã¯çµç¹å¹é€ã«ãããŠå€å°ã®ãã€ã³ãã©ãºãæ
å¶æŽ»æ§ã®å¢å ãèŠãããããšããã€ãŠãæ®ãã©çž
ä¹å¹æã¯ç€ºããªãã çžä¹å¹æã®ããåå€ãçµæãããã¯ãã©ã€ãã
ãã³ã¢ããã°ãªã³ã·ãæçç©è³ªã¯ãéé¢å¡©åºã§ã
ã€ãŠãããããé©åœãªé žä»å å¡©ã§ãã€ãŠãããã
ãããã®æçç©è³ªã¯é±é žããã³ã«ã«ãã³é žãšå¡©ã
圢æããããã®çš®ã®å¡©ã®äŸãšããŠã¯ãã¿ã€ãã·ã³
å¡©é žå¡©ãã¿ã€ãã·ã³é ç³é žå¡©ãã¿ã€ãã·ã³ãªã³é ž
å¡©ãã¹ãããã€ã·ã³ã¢ãžãã³é žå¡©ãã¹ãããã€ã·
ã³å¡©é žå¡©ããªã¬ã¢ã³ããã€ã·ã³å¡©é žå¡©ããã€ã³ã
ã€ã·ã³èåæ°ŽçŽ é žå¡©ããã°ããã€ã·ã³é ç³é žå¡©ã
ããã©ãã€ã·ã³ç¡«é žå¡©ãã¢ãã©ãã€ã·ã³å¡©é žå¡©ã
ãªãã€ã·ã³ç¡«é žå¡©ãããªãã€ã·ã³å¡©é žå¡©ãã²ã³ã¿
ãã€ã·ã³å¡©é žå¡©ãã²ã³ã¿ãã€ã·ã³ç¡«é žå¡©ãããã æ¬çºæã®æçç©è³ªè£œå€ã¯éé¢å¡©åºãŸãã¯å¡©ã®åœ¢
ã§æçç©è³ªã®ä¹Ÿç¥ç²æ«ãæ··åããããšã«ãã€ãŠè£œ
é ãããããããã¯ãé©åœãªæ¿åºŠã®æçç©è³ªã®æº¶
液ãæ··åããäºã€ã®æçç©è³ªãææã®æ¿åºŠã§å«ã
溶液ãåŸãŠããããããããã®æçç©è³ªã¯æ°Žæ§åª
質ã«å åå¯æº¶ã§ãããæ°Žæ§çµç¹å¹é€çšå¹å°ãçšã
ã溶液補å€ã¯ãåºä¹³åç©ã®çµç¹å¹é€ã«ããããã€
ã³ãã©ãºãæ±æãå¶åŸ¡ããã®ã«å¥œé©ã§ããã æ¬çºæã®çžä¹æ§æçç©è³ªåå€ã¯ãåºç¯ãªåºä¹³å
ç©çµç¹ã«ããããã€ã³ãã©ãºãã®çè²ãé»æ¢ãã
åŸã€ãŠãããçµç¹ã®æ±æããã³æ倱ãé²æ¢ããã
ãã«çšãããããããšãã°ãç±³åœç¹èš±3904480
ïŒHull et alïŒã«èšèŒãããŠããæ¹æ³ã«ãããã©
ã¹ããã²ã³æŽ»æ§åå€ã®è£œé ã«ãããåºä¹³åç©ã®çµ
ç¹å¹é€ã«ãæ¬çºæã®åå€ã䜿çšããããšãã§ã
ãã æ¬çºæã®æçç©è³ªåå€ã¯ããã¯ãã©ã€ãæçç©
質ãšã¢ããã°ãªã³ã·ãæçç©è³ªãšã®ééæ¯ã15ïŒ
ïŒä¹è³ïŒïŒ15ããã€ãŠæ§æãããããã¯ãã©ã€ã
ãšã¢ããã°ãªã³ã·ãã®å¥œãŸããééæ¯ã¯ïŒïŒïŒä¹
è³ïŒïŒïŒã§ããã æ¬çºææçç©è³ªåå€ã®å¥œãŸããäžåœ¢æ ã§ããã¿
ã€ãã·ã³ãšã¢ãã©ãã€ã·ã³ã®åå€ã¯ãé¢ä¹³åŸã®è±
ã®çºè²ãå¢é²ããããã«ãçšãããåŸããã¿ã€ã
ã·ã³âã¢ãã©ãã€ã·ã³åå€ã¯ãé¢ä¹³åŸã®è±ã«ãã
ãŠãããããã®æçç©è³ªãåç¬ã§çšããå Žåãã
ããããé«ã飌ææåãšããé«ãäœéå¢å ããã
ãããé¢ä¹³åŸã®è±ã«ããã飌ææåããã³äœéå¢
å ã«å¯Ÿããã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®å¹
æã¯ãäžèšã®æ¹æ³ã«ããåç©å®éšã§èšŒæããã å®éšã¯ãçèïŒpenïŒåœãïŒé ã®è±ãå容ãã
è€æ°ã®çèãçšããŠ28æ¥éå®æœããã䜿çšããè±
ã¯ãééæ··æã§ãå¹³ååæäœé12.89Kgãå¹³å什
ïŒé±ã§ãã€ããåç©ã«ã¯ã飌æãäžããååŸã«æ°Ž
ãäžããïŒæ¥ïŒåãäžèšçµæã®é£Œæãäžããã æ å çŸåæ¯ å°éºŠ 21 倧麊 23.5 ããŠã¢ãã³ã· 20 éè 2.5 ã€ãŒã¹ã 1 å°éºŠãã¹ã 10 ã¢ã«ãã¢ã«ã㢠2.5 倧è±ç² 14 ã«ã©ã¹ã ã®ç®ïŒoat hullsïŒ 1.8 ãªã³é žã«ã«ã·ãŠã 1 çé žã«ã«ã·ãŠã 1.1 å¡©åãããªãŠã 0.1 ãã¬ããã¯ã¹SV12 1 ãã¬ããã¯ã¹SO4 0.5 å®éšã§ã¯ãã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã
ã¿ã€ãã·ã³ããã³ã¢ãã©ãã€ã·ã³ã® ãããå
ç¬äœ¿çšãšæ¯èŒããã åæçç©è³ªããã³ãããã®åå€ã¯ãåç©é£Œæã«
å ããŠæäžãããåæçç©è³ªã®æ··åæ¯ã¯ãåç¬ã®
å Žåã¯100ppmãåå€ã®å Žåã¯ãããã100ppmãš
ããã ïŒåã®åæ§ã®å®éšã®ç·åçµæã¯ãäžèšã®è¡šïŒã«
瀺ãããŠããã
ã·ã³åå€ã¯ã3.5é±éã«ããã€ãŠå®æœããïŒâïŒ
åã®ãµã³ããªã³ã°ã«ãããŠãã€ã³ãã©ãºãã®çè²
ãé»æ¢ãããåç¬äœ¿çšã®å Žåã¯ãã¿ã€ãã·ã³ãã
ãã©ãã€ã·ã³å ±ã«è¡šïŒã«ç€ºããããã«é¥ãã«é«ã
MICå€ã瀺ãã è¡šïŒã®æ°å€ã¯ãäœæ¿åºŠã§æ¬çºæã®æçç©è³ªåå€
ãçžä¹çã«æå¹ã§ããããšã瀺ããŠãããïŒéé
éšä»¥äžã®ããã©ãã€ã·ã³ã«å¯ŸããŠïŒéééšä»¥äžã®
ã¿ã€ãã·ã³ãå«ãåå€ã奜ãŸããçžä¹ççµæç©ã§
ããã æ¬çºæã®ãä»ã®å¥œãŸããåå€ã¯ããã©ãã€ã·ã³
ãšã¢ãã©ãã€ã·ã³ã®çµåãã§ãããè¡šïŒã«ç€ºãã
ãŠããããã«ãã¿ã€ãã·ã³12mcgïŒmlãšã¢ãã©ã
ã€ã·ã³12mcgïŒmlãå«ã溶液ã¯ãã€ã³ãã©ãºãã
é»æ¢ããããã¢ãã©ãã€ã·ã³åç¬ã®MICã¯
600mcgïŒmlã§ãããã¿ã€ãã·ã³ã®ããã¯
200mcgïŒmlã§ããã ä»ã®å¥œãŸããåå€ã¯ãã¿ã€ãã·ã³ãšã²ã³ã¿ãã€
ã·ã³ã®çµåãã§ããã æ¬çºæã®ãã¯ãã©ã€ãæçç©è³ªãšã¢ããã°ãªã³
ã·ãæçç©è³ªãšã®åå€ã§çžä¹äœçšã蚌æãããã®
ã«ããã¯ãã©ã€ãâãã¯ãã©ã€ãæçç©è³ªåå€ã®
å€ãã¯çµç¹å¹é€ã«ãããŠå€å°ã®ãã€ã³ãã©ãºãæ
å¶æŽ»æ§ã®å¢å ãèŠãããããšããã€ãŠãæ®ãã©çž
ä¹å¹æã¯ç€ºããªãã çžä¹å¹æã®ããåå€ãçµæãããã¯ãã©ã€ãã
ãã³ã¢ããã°ãªã³ã·ãæçç©è³ªã¯ãéé¢å¡©åºã§ã
ã€ãŠãããããé©åœãªé žä»å å¡©ã§ãã€ãŠãããã
ãããã®æçç©è³ªã¯é±é žããã³ã«ã«ãã³é žãšå¡©ã
圢æããããã®çš®ã®å¡©ã®äŸãšããŠã¯ãã¿ã€ãã·ã³
å¡©é žå¡©ãã¿ã€ãã·ã³é ç³é žå¡©ãã¿ã€ãã·ã³ãªã³é ž
å¡©ãã¹ãããã€ã·ã³ã¢ãžãã³é žå¡©ãã¹ãããã€ã·
ã³å¡©é žå¡©ããªã¬ã¢ã³ããã€ã·ã³å¡©é žå¡©ããã€ã³ã
ã€ã·ã³èåæ°ŽçŽ é žå¡©ããã°ããã€ã·ã³é ç³é žå¡©ã
ããã©ãã€ã·ã³ç¡«é žå¡©ãã¢ãã©ãã€ã·ã³å¡©é žå¡©ã
ãªãã€ã·ã³ç¡«é žå¡©ãããªãã€ã·ã³å¡©é žå¡©ãã²ã³ã¿
ãã€ã·ã³å¡©é žå¡©ãã²ã³ã¿ãã€ã·ã³ç¡«é žå¡©ãããã æ¬çºæã®æçç©è³ªè£œå€ã¯éé¢å¡©åºãŸãã¯å¡©ã®åœ¢
ã§æçç©è³ªã®ä¹Ÿç¥ç²æ«ãæ··åããããšã«ãã€ãŠè£œ
é ãããããããã¯ãé©åœãªæ¿åºŠã®æçç©è³ªã®æº¶
液ãæ··åããäºã€ã®æçç©è³ªãææã®æ¿åºŠã§å«ã
溶液ãåŸãŠããããããããã®æçç©è³ªã¯æ°Žæ§åª
質ã«å åå¯æº¶ã§ãããæ°Žæ§çµç¹å¹é€çšå¹å°ãçšã
ã溶液補å€ã¯ãåºä¹³åç©ã®çµç¹å¹é€ã«ããããã€
ã³ãã©ãºãæ±æãå¶åŸ¡ããã®ã«å¥œé©ã§ããã æ¬çºæã®çžä¹æ§æçç©è³ªåå€ã¯ãåºç¯ãªåºä¹³å
ç©çµç¹ã«ããããã€ã³ãã©ãºãã®çè²ãé»æ¢ãã
åŸã€ãŠãããçµç¹ã®æ±æããã³æ倱ãé²æ¢ããã
ãã«çšãããããããšãã°ãç±³åœç¹èš±3904480
ïŒHull et alïŒã«èšèŒãããŠããæ¹æ³ã«ãããã©
ã¹ããã²ã³æŽ»æ§åå€ã®è£œé ã«ãããåºä¹³åç©ã®çµ
ç¹å¹é€ã«ãæ¬çºæã®åå€ã䜿çšããããšãã§ã
ãã æ¬çºæã®æçç©è³ªåå€ã¯ããã¯ãã©ã€ãæçç©
質ãšã¢ããã°ãªã³ã·ãæçç©è³ªãšã®ééæ¯ã15ïŒ
ïŒä¹è³ïŒïŒ15ããã€ãŠæ§æãããããã¯ãã©ã€ã
ãšã¢ããã°ãªã³ã·ãã®å¥œãŸããééæ¯ã¯ïŒïŒïŒä¹
è³ïŒïŒïŒã§ããã æ¬çºææçç©è³ªåå€ã®å¥œãŸããäžåœ¢æ ã§ããã¿
ã€ãã·ã³ãšã¢ãã©ãã€ã·ã³ã®åå€ã¯ãé¢ä¹³åŸã®è±
ã®çºè²ãå¢é²ããããã«ãçšãããåŸããã¿ã€ã
ã·ã³âã¢ãã©ãã€ã·ã³åå€ã¯ãé¢ä¹³åŸã®è±ã«ãã
ãŠãããããã®æçç©è³ªãåç¬ã§çšããå Žåãã
ããããé«ã飌ææåãšããé«ãäœéå¢å ããã
ãããé¢ä¹³åŸã®è±ã«ããã飌ææåããã³äœéå¢
å ã«å¯Ÿããã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®å¹
æã¯ãäžèšã®æ¹æ³ã«ããåç©å®éšã§èšŒæããã å®éšã¯ãçèïŒpenïŒåœãïŒé ã®è±ãå容ãã
è€æ°ã®çèãçšããŠ28æ¥éå®æœããã䜿çšããè±
ã¯ãééæ··æã§ãå¹³ååæäœé12.89Kgãå¹³å什
ïŒé±ã§ãã€ããåç©ã«ã¯ã飌æãäžããååŸã«æ°Ž
ãäžããïŒæ¥ïŒåãäžèšçµæã®é£Œæãäžããã æ å çŸåæ¯ å°éºŠ 21 倧麊 23.5 ããŠã¢ãã³ã· 20 éè 2.5 ã€ãŒã¹ã 1 å°éºŠãã¹ã 10 ã¢ã«ãã¢ã«ã㢠2.5 倧è±ç² 14 ã«ã©ã¹ã ã®ç®ïŒoat hullsïŒ 1.8 ãªã³é žã«ã«ã·ãŠã 1 çé žã«ã«ã·ãŠã 1.1 å¡©åãããªãŠã 0.1 ãã¬ããã¯ã¹SV12 1 ãã¬ããã¯ã¹SO4 0.5 å®éšã§ã¯ãã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã
ã¿ã€ãã·ã³ããã³ã¢ãã©ãã€ã·ã³ã® ãããå
ç¬äœ¿çšãšæ¯èŒããã åæçç©è³ªããã³ãããã®åå€ã¯ãåç©é£Œæã«
å ããŠæäžãããåæçç©è³ªã®æ··åæ¯ã¯ãåç¬ã®
å Žåã¯100ppmãåå€ã®å Žåã¯ãããã100ppmãš
ããã ïŒåã®åæ§ã®å®éšã®ç·åçµæã¯ãäžèšã®è¡šïŒã«
瀺ãããŠããã
ãè¡šã
ãè¡šã
è¡šïŒã«ãããçµ±èšèšå·ã®æ矩ã¯æ¬¡ã®ãšããã§ã
ãã
ïŒå¹³åå€ïŒÂ± ïœïŒæšæºåå·®ïŒïœïŒå€åä¿æ°ïŒ ïŒRelïŒïŒãã¬ãã€ãã³ã³ãããŒã«ã100ãšããæ¯
èŒå€ã è¡šïŒããæãããªããã«ãã¿ã€ãã·ã³âã¢ãã©
ãã€ã·ã³åå€ã§åŠçœ®ããè±ã¯ã28æ¥éã®å®éšã«ã
ããŠãã¿ã€ãã·ã³åç¬ãŸãã¯ã¢ãã©ãã€ã·ã³åç¬
ã§åŠçœ®ããè±ããé«ãäœéå¢å ãšè¯å¥œãªé£Œæå¹ç
ã瀺ããã 次ã«ãã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®å¹å
ã¯ãé¢ä¹³è±ã®ã³ã³ãããŒã«è©Šéšã«ãã€ãŠæããã«
ãããããã®çµæã¯ãæ¬æçç©è³ªåå€ã§åŠçœ®ãã
è±ã¯ãã¢ãã©ãã€ã·ã³åç¬ãŸãã¯ã¿ã€ãã·ã³åç¬
ã§åŠçããè±ã«æ¯ããŠãå€§è žèäžç¢ã®é »åºŠã極ã
ãŠèãããäœæžãããããšã瀺ããŠãããããã«
該åå€ãäžããè±ã¯ãããããäžæ¹ã®æçç©è³ªã
äžããè±ã«æ¯ããŠãããé«ãïŒæ¥åœãã®äœéå¢å
ã瀺ãããã€ããæ¹åããã飌æå¹çã瀺ããã 次ã®è¡šïŒã¯ãé¢ä¹³è±ãçšããŠ21æ¥éã§åŸããã
çµæã瀺ããŠãããã¿ã€ãã·ã³ããã³ã¢ãã©ãã€
ã·ã³ã¯ããããã110ppmã®å²åã§é£Œæã«æ··å ¥ã
ãŠæäžãããåæ§ã«ããŠæçç©è³ªåå€ã¯ã
110ppmã®å²åã§äž¡æçç©è³ªã飌æã«å«ãŸããŠæ
äžãããçµæã¯ãè©Šéšã§åŸãããæ°å€ãçµ±èšçã«
è©äŸ¡ããæªåŠçœ®ã®ã³ã³ãããŒã«çŸ€ãè¶ããå¢å å
ãçŸåçã§ç€ºãã
ãã
ïŒå¹³åå€ïŒÂ± ïœïŒæšæºåå·®ïŒïœïŒå€åä¿æ°ïŒ ïŒRelïŒïŒãã¬ãã€ãã³ã³ãããŒã«ã100ãšããæ¯
èŒå€ã è¡šïŒããæãããªããã«ãã¿ã€ãã·ã³âã¢ãã©
ãã€ã·ã³åå€ã§åŠçœ®ããè±ã¯ã28æ¥éã®å®éšã«ã
ããŠãã¿ã€ãã·ã³åç¬ãŸãã¯ã¢ãã©ãã€ã·ã³åç¬
ã§åŠçœ®ããè±ããé«ãäœéå¢å ãšè¯å¥œãªé£Œæå¹ç
ã瀺ããã 次ã«ãã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®å¹å
ã¯ãé¢ä¹³è±ã®ã³ã³ãããŒã«è©Šéšã«ãã€ãŠæããã«
ãããããã®çµæã¯ãæ¬æçç©è³ªåå€ã§åŠçœ®ãã
è±ã¯ãã¢ãã©ãã€ã·ã³åç¬ãŸãã¯ã¿ã€ãã·ã³åç¬
ã§åŠçããè±ã«æ¯ããŠãå€§è žèäžç¢ã®é »åºŠã極ã
ãŠèãããäœæžãããããšã瀺ããŠãããããã«
該åå€ãäžããè±ã¯ãããããäžæ¹ã®æçç©è³ªã
äžããè±ã«æ¯ããŠãããé«ãïŒæ¥åœãã®äœéå¢å
ã瀺ãããã€ããæ¹åããã飌æå¹çã瀺ããã 次ã®è¡šïŒã¯ãé¢ä¹³è±ãçšããŠ21æ¥éã§åŸããã
çµæã瀺ããŠãããã¿ã€ãã·ã³ããã³ã¢ãã©ãã€
ã·ã³ã¯ããããã110ppmã®å²åã§é£Œæã«æ··å ¥ã
ãŠæäžãããåæ§ã«ããŠæçç©è³ªåå€ã¯ã
110ppmã®å²åã§äž¡æçç©è³ªã飌æã«å«ãŸããŠæ
äžãããçµæã¯ãè©Šéšã§åŸãããæ°å€ãçµ±èšçã«
è©äŸ¡ããæªåŠçœ®ã®ã³ã³ãããŒã«çŸ€ãè¶ããå¢å å
ãçŸåçã§ç€ºãã
ãè¡šã
è¡šïŒã«ç€ºãããŠããããã«ãã¿ã€ãã·ã³ã¯ãå
ç¬äœ¿çšã®å Žåã§ãã飌æå¹çã®æ¹åãäœéå¢å ã
ãã³äžç¢åæ°ã®äœæžã«æå¹ã§ãã€ããã¢ãã©ãã€
ã·ã³ã¯ãåç¬äœ¿çšã«ãããŠãããããã®æ€å®é ç®
ã«ã€ããŠæ¢ç¥ã®å¹æã瀺ãããæå€ã«ããäž¡æç
ç©è³ªãçµåããŠäœ¿çšãããšãã¢ãã©ãã€ã·ã³åç¬
䜿çšã®å Žåããããåé ç®ã«ã€ãè倧ãªæ¹åã瀺
ãããåè¿°ã®ãšãããã¿ã€ãã·ã³ãé¢ä¹³åŸã®è±ã«
ãããå€§è žèçã«æå¹ã§ããããšã¯ãããŸã§ç¥ã
ããŠããªãã€ãã®ã§ãã¢ãã©ãã€ã·ã³åç¬ã®å Žå
ããåªããã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®å¹
æã¯äºæããªããã®ã§ãã€ãã æ¬çºæã®æ¹æ³ã¯ãã¿ã€ãã·ã³ããã³ã¢ãã©ãã€
ã·ã³ã®æ²»ççã«æå¹ãªéãé¢ä¹³è±ã«æäžããããš
ãããªããæäžãåŸãäž¡æçç©è³ªã®åèšéããã³
ãã®é åæ¯ã¯å€ãåŸããåç©é£Œæã«ãããæçç©
質ã®æå¹æ··åæ¯ã¯ãçŸç ã®é節床ãåç©ä»€ããã³
äœéçã®è«žå åã«ãã€ãŠå€ããäž¡æçç©è³ªãåã
ã飌æäžã®æ··åæ¯ã¯50ppmä¹è³1000ppmã§ããã
ã¿ã€ãã·ã³ãšã¢ãã©ãã€ã·ã³ãšã®ééæ¯ã¯ãïŒïŒ
ïŒä¹è³ïŒïŒïŒã§ãããäžè¬çã«æçšãªäž¡æçç©è³ª
ãåãã飌æãžã®æ··åæ¯ã¯ã100ppmä¹è³300ppm
ã§ããã奜ãŸããæ··åæ¯ã¯çŽ200ppmã§ãããäž¡
æçç©è³ªã®ééæ¯ã¯ïŒïŒïŒã§ããã ã¿ã€ãã·ã³ããã³ã¢ãã©ãã€ã·ã³ã¯å¡©åºæ§ç©è³ª
ã§ãããé±é žãã«ã«ãã³é žããã³ã¹ã«ãã³é žãšå¡©
ã圢æãããããšãã°ãå¡©é žå¡©ãç¡«é žå¡©ããªã³é ž
å¡©ãé ç³é žå¡©ãã¯ãšã³é žå¡©ãã©ãŠãªã«ã¹ã«ãã³é ž
å¡©ããããµã³é žå¡©ããã³ãŒã³ã¹ã«ãã³é žå¡©çã§ã
ããæ¬çºæã®æ¹æ³ã«ãããŠãæçç©è³ªã¯éé¢å¡©åº
ã®åœ¢ã°ããã§ãªããå¡©ã®åœ¢ã§ã䜿çšããåŸããã¿
ã€ãã·ã³ã®å¥œãŸããå¡©ã¯ãé ç³é žå¡©ããã³ãªã³é ž
å¡©ã§ããã奜ãŸããã¢ãã©ãã€ã·ã³ã®å¡©ã¯ãç¡«é ž
å¡©ããã³å¡©é žå¡©ã§ããã ã¿ã€ãã·ã³ããã³ã¢ãã©ãã€ã·ã³ã¯ãäž¡è ãã
ã¬ããã¯ã¹ã«å«ããŠè£œååããŠããããããŸãåŸ
ã§é£Œæã«æ·»å ããããã®ãã¬ããã¯ã¹ãšããŠãã
ãããŸãããã®äºã€ã®æçç©è³ªãçŽæ¥æçµé£Œæã«
æ··åããŠãããã å¡©åºåœ¢ã®æçç©è³ªã¯ããã®å¡©é¡ãšåæ§ã«ãæ°Žã«
å¯æã溶ããããããæçç©è³ªã¯ã奜ãŸããã¯å¡©
ã®åœ¢ã§åç©ã®é£²ææ°Žã«å ããŠãæ²»çäžæå¹ãªæ¿åºŠ
ã®æº¶æ¶²ãšããŠãããã飌æã®å Žåãšåæ§ã«ã飲æ
æ°Žäžã®æçç©è³ªã®æ¿åºŠãå€ãåŸããäž¡æçç©è³ªã®
æ¿åºŠã10mcgïŒmlä¹è³500mcgïŒmlã§ãæçç©è³ª
çžäºã®ééæ¯ãïŒïŒïŒä¹è³ïŒïŒïŒã§ããã°ãåç©
ã«å¯ŸããŠææã®å¹æãããããã®ã«äžè¬ã«å åã§
ããã飲ææ°Žäžã®å¥œãŸããæçç©è³ªæ¿åºŠã¯
50mcgïŒmlä¹è³300mcgïŒmlã§ããã ã¿ã€ãã·ã³ããã³ã¢ãã©ãã€ã·ã³ãããªãæç
ç©è³ªåå€ã¯ãåç©é£ŒæãŸãã¯é£²ææ°Žã«æ··ããŠæäž
ããã®ãæãå®éçã§ããããè±ã«å¯ŸããŠæ³šå°æ
äžããŠãæå¹ã§ããã泚å°æäžçšã«ã¯ãäž¡æçç©
質ãé©åœãªè£œè¬äžèš±å®¹ãããçšéå€ïŒããšãã°ã
æ°Žãççé£å¡©æ°Žãããã¹ãããŒãºïŒãšå ±ã«è£œå€ã
ãããšãã§ãããã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³å
å€ã®æ³šå°æäžã¯ãé¢ä¹³è±ãçŸç ã«ãã衰匱ã®ãã
å åãªéã®è¬ç©æ·»å é£ç©ãæåãåŸãªãå Žåã®æ²»
çã«çšããããããã®çš®ã®å Žåã«ã¯ãæçç©è³ªå
å€ãè±ã«å¯ŸããŠæ¯æ¥æ³šå°æäžããããŸããããã
ã®æçç©è³ªãé©åœãªçµå£æäžéå€åïŒããšãã°ã
é å€ãã«ãã»ã«å€ãæžæ¿å€ïŒã«è£œå€ããŠãè¬å€æ·»
å 飌æã®å åéãå«é£ãåŸãªãè±ã«æäžããããš
ãã§ããã ã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®å€§è žèçã«
察ããæ²»çäºé²å¹æã¯ãé¢ä¹³è±ãçšãã21æ¥éã®
è©Šéšçµæã«ãã€ãŠç€ºããããè±ãäœéã«ãããïŒ
é ãã€ã®åŠçœ®ããã³ã³ã³ãããŒã«çŸ€ã«åãããå
åŠçœ®ã¯ãç¡äœçºã«ïŒçŸ€ã«å²åœãŠãåç©ã¯éåžžã®é£Œ
æãä»»æã«æåãããäžæ¹ãåŠçœ®çŸ€ã«ã¯åæçç©
質110ppmãå«ã飌æãäžãããäœéå¢å ã飌æ
å¹çããã³äžç¢ã®é »åºŠããåŠçœ®ã«å¯Ÿããå¿çãšã
ãŠèŠ³å¯ããã21æ¥åŸã«åŸãããçµæã¯ãè¡šïŒã«ç€º
ãããŠããã
ç¬äœ¿çšã®å Žåã§ãã飌æå¹çã®æ¹åãäœéå¢å ã
ãã³äžç¢åæ°ã®äœæžã«æå¹ã§ãã€ããã¢ãã©ãã€
ã·ã³ã¯ãåç¬äœ¿çšã«ãããŠãããããã®æ€å®é ç®
ã«ã€ããŠæ¢ç¥ã®å¹æã瀺ãããæå€ã«ããäž¡æç
ç©è³ªãçµåããŠäœ¿çšãããšãã¢ãã©ãã€ã·ã³åç¬
䜿çšã®å Žåããããåé ç®ã«ã€ãè倧ãªæ¹åã瀺
ãããåè¿°ã®ãšãããã¿ã€ãã·ã³ãé¢ä¹³åŸã®è±ã«
ãããå€§è žèçã«æå¹ã§ããããšã¯ãããŸã§ç¥ã
ããŠããªãã€ãã®ã§ãã¢ãã©ãã€ã·ã³åç¬ã®å Žå
ããåªããã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®å¹
æã¯äºæããªããã®ã§ãã€ãã æ¬çºæã®æ¹æ³ã¯ãã¿ã€ãã·ã³ããã³ã¢ãã©ãã€
ã·ã³ã®æ²»ççã«æå¹ãªéãé¢ä¹³è±ã«æäžããããš
ãããªããæäžãåŸãäž¡æçç©è³ªã®åèšéããã³
ãã®é åæ¯ã¯å€ãåŸããåç©é£Œæã«ãããæçç©
質ã®æå¹æ··åæ¯ã¯ãçŸç ã®é節床ãåç©ä»€ããã³
äœéçã®è«žå åã«ãã€ãŠå€ããäž¡æçç©è³ªãåã
ã飌æäžã®æ··åæ¯ã¯50ppmä¹è³1000ppmã§ããã
ã¿ã€ãã·ã³ãšã¢ãã©ãã€ã·ã³ãšã®ééæ¯ã¯ãïŒïŒ
ïŒä¹è³ïŒïŒïŒã§ãããäžè¬çã«æçšãªäž¡æçç©è³ª
ãåãã飌æãžã®æ··åæ¯ã¯ã100ppmä¹è³300ppm
ã§ããã奜ãŸããæ··åæ¯ã¯çŽ200ppmã§ãããäž¡
æçç©è³ªã®ééæ¯ã¯ïŒïŒïŒã§ããã ã¿ã€ãã·ã³ããã³ã¢ãã©ãã€ã·ã³ã¯å¡©åºæ§ç©è³ª
ã§ãããé±é žãã«ã«ãã³é žããã³ã¹ã«ãã³é žãšå¡©
ã圢æãããããšãã°ãå¡©é žå¡©ãç¡«é žå¡©ããªã³é ž
å¡©ãé ç³é žå¡©ãã¯ãšã³é žå¡©ãã©ãŠãªã«ã¹ã«ãã³é ž
å¡©ããããµã³é žå¡©ããã³ãŒã³ã¹ã«ãã³é žå¡©çã§ã
ããæ¬çºæã®æ¹æ³ã«ãããŠãæçç©è³ªã¯éé¢å¡©åº
ã®åœ¢ã°ããã§ãªããå¡©ã®åœ¢ã§ã䜿çšããåŸããã¿
ã€ãã·ã³ã®å¥œãŸããå¡©ã¯ãé ç³é žå¡©ããã³ãªã³é ž
å¡©ã§ããã奜ãŸããã¢ãã©ãã€ã·ã³ã®å¡©ã¯ãç¡«é ž
å¡©ããã³å¡©é žå¡©ã§ããã ã¿ã€ãã·ã³ããã³ã¢ãã©ãã€ã·ã³ã¯ãäž¡è ãã
ã¬ããã¯ã¹ã«å«ããŠè£œååããŠããããããŸãåŸ
ã§é£Œæã«æ·»å ããããã®ãã¬ããã¯ã¹ãšããŠãã
ãããŸãããã®äºã€ã®æçç©è³ªãçŽæ¥æçµé£Œæã«
æ··åããŠãããã å¡©åºåœ¢ã®æçç©è³ªã¯ããã®å¡©é¡ãšåæ§ã«ãæ°Žã«
å¯æã溶ããããããæçç©è³ªã¯ã奜ãŸããã¯å¡©
ã®åœ¢ã§åç©ã®é£²ææ°Žã«å ããŠãæ²»çäžæå¹ãªæ¿åºŠ
ã®æº¶æ¶²ãšããŠãããã飌æã®å Žåãšåæ§ã«ã飲æ
æ°Žäžã®æçç©è³ªã®æ¿åºŠãå€ãåŸããäž¡æçç©è³ªã®
æ¿åºŠã10mcgïŒmlä¹è³500mcgïŒmlã§ãæçç©è³ª
çžäºã®ééæ¯ãïŒïŒïŒä¹è³ïŒïŒïŒã§ããã°ãåç©
ã«å¯ŸããŠææã®å¹æãããããã®ã«äžè¬ã«å åã§
ããã飲ææ°Žäžã®å¥œãŸããæçç©è³ªæ¿åºŠã¯
50mcgïŒmlä¹è³300mcgïŒmlã§ããã ã¿ã€ãã·ã³ããã³ã¢ãã©ãã€ã·ã³ãããªãæç
ç©è³ªåå€ã¯ãåç©é£ŒæãŸãã¯é£²ææ°Žã«æ··ããŠæäž
ããã®ãæãå®éçã§ããããè±ã«å¯ŸããŠæ³šå°æ
äžããŠãæå¹ã§ããã泚å°æäžçšã«ã¯ãäž¡æçç©
質ãé©åœãªè£œè¬äžèš±å®¹ãããçšéå€ïŒããšãã°ã
æ°Žãççé£å¡©æ°Žãããã¹ãããŒãºïŒãšå ±ã«è£œå€ã
ãããšãã§ãããã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³å
å€ã®æ³šå°æäžã¯ãé¢ä¹³è±ãçŸç ã«ãã衰匱ã®ãã
å åãªéã®è¬ç©æ·»å é£ç©ãæåãåŸãªãå Žåã®æ²»
çã«çšããããããã®çš®ã®å Žåã«ã¯ãæçç©è³ªå
å€ãè±ã«å¯ŸããŠæ¯æ¥æ³šå°æäžããããŸããããã
ã®æçç©è³ªãé©åœãªçµå£æäžéå€åïŒããšãã°ã
é å€ãã«ãã»ã«å€ãæžæ¿å€ïŒã«è£œå€ããŠãè¬å€æ·»
å 飌æã®å åéãå«é£ãåŸãªãè±ã«æäžããããš
ãã§ããã ã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®å€§è žèçã«
察ããæ²»çäºé²å¹æã¯ãé¢ä¹³è±ãçšãã21æ¥éã®
è©Šéšçµæã«ãã€ãŠç€ºããããè±ãäœéã«ãããïŒ
é ãã€ã®åŠçœ®ããã³ã³ã³ãããŒã«çŸ€ã«åãããå
åŠçœ®ã¯ãç¡äœçºã«ïŒçŸ€ã«å²åœãŠãåç©ã¯éåžžã®é£Œ
æãä»»æã«æåãããäžæ¹ãåŠçœ®çŸ€ã«ã¯åæçç©
質110ppmãå«ã飌æãäžãããäœéå¢å ã飌æ
å¹çããã³äžç¢ã®é »åºŠããåŠçœ®ã«å¯Ÿããå¿çãšã
ãŠèŠ³å¯ããã21æ¥åŸã«åŸãããçµæã¯ãè¡šïŒã«ç€º
ãããŠããã
ãè¡šã
å¥æ·»ã®å³è¡šã¯ãäžèšã®è©Šéšã§åŸãããå¹³åäžç¢
è©ç¹ãæéïŒæ¥ïŒã«å¯ŸããŠããããããã°ã©ãã§
ãããããããã¯ãã³ã³ãããŒã«çŸ€ããã³ååŠçœ®
矀ã®å¹³åè©ç¹ã§è¡ã€ããã¿ã€ãã·ã³âã¢ãã©ãã€
ã·ã³åå€åŠçœ®çŸ€ã®å¹³åè©ç¹ããããã瀺ããŠãã
ããã«ãäžç¢é »åºŠã¯ã¢ãã©ãã€ã·ã³åç¬åŠçœ®çŸ€ã§
ã®é »åºŠããèããäœãã€ãããã®ã°ã©ãã¯ãŸãã
ã¿ã€ãã·ã³åç¬ã§ãäžç¢é »åºŠã®äœæžã«ããçšåºŠæ
å¹ã§ããããšã瀺ããŠããã æ¬çºæã®æ¹æ³ãå®æœããã«ã¯ãè±ãé¢ä¹³æãã
é¢ä¹³åŸïŒâïŒé±éæ¬æçç©è³ªåå€ã§åŠçœ®ãããç
ç¶ãé節ã§ãããšãã¯ãå¿ èŠã«å¿ããŠããã«é·æ
æ²»çããããšãã§ããã åèšè¡šïŒã«è¡šç€ºããæ°å€ã¯ãåŠçœ®çŸ€ãšã³ã³ãã
ãŒã«çŸ€ãšã®éã®äžç¢é »åºŠã®çžéããã³ã³ãããŒã«
矀ã«å¯ŸããçŸåçã§ç€ºããŠããã æ¬çºæã®ã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã¯ã
ãã¹ããŠã¬ã©ã»ãã¢ãªãã€ã«ã®æ ªïŒPasteurella
hemolytica strainsïŒã«å¯ŸããŠçžä¹ç掻æ§ãæã
ãããã®åŸ®çç©ã¯çã®èºçãèµ·ããé節ãªææã¯
æ»ã«è³ãããããã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³å
å€ã®çžä¹å¹æã¯ãP.hemolytica41Dæ ªã«å¯Ÿããin
vitroè©Šéšã§èšŒæããããã¿ã€ãã·ã³åç¬ã®æå°
çºè²é»æ¢æ¿åºŠã¯50mcgïŒmlã§ãããã¢ãã©ãã€ã·
ã³åç¬ã®ããã¯25mcgïŒmlã§ãã€ããäºã€ã®æç
ç©è³ªã®åå€ã®çžä¹ç掻æ§ã¯ãæè¬âããšãã«ãŒã
ãŒãâ滎å®æ³ã«ãã€ãŠèšŒæãããããã®æ¹æ³ã§
ã¯ãäºã€ã®æçç©è³ªãšé 次çšéããåçšé床ããš
ã«ãããã«åçšé床ã®ãã¹ãŠã®çµåãã«ã€ããŠæ€
å®ãè¡ã€ãŠã被éšã®çè²ãé»æ¢ããæ¿åºŠããåæ
çç©è³ªåç¬ããã³äž¡è ã®çµåãã«ã€ããŠæ±ããã
äž¡æçç©è³ªã®çžäºäœçšã¯ã代æ°åŠçãŸãã¯å¹ŸäœåŠ
çã«æ±ºå®ããåŸãã代æ°åŠçææ³ã§ã¯ãçè²ãé»
æ¢ããçµåãã«ãããåæçç©è³ªã®æ¿åºŠãããã®
æçç©è³ªãåç¬ã§äœ¿çšããŠåäžã®å¹æãåŸããšã
ã®æ¿åºŠãšã®æ¯ã§æ±ããããã®æ¯ã®åèšãïŒã§ãã
ã°ãã®çµåãã¯çžå çã§ããããã®åèšãïŒãã
å°ãããã°ãã®çµåãã¯çžä¹çã§ããããããŠã
ã®åèšãïŒãã倧ãããã°ãã®çµåãã¯æ®æçã§
ããããšã«ãªãã ã¿ã€ãã·ã³ãã¢ãã©ãã€ã·ã³ããã³äž¡è ã®çµå
ãã®P.hemolyticaã«å¯Ÿããin vitroè©Šéšã§åŸãæ°
å€ãçšããèšç®çµæã以äžã«ç€ºãã ã¿ã€ãã·ã³åç¬MICïŒ50mcgïŒml ã¢ãã©ãã€ã·ã³åç¬MICïŒ25mcgïŒml ã¿ã€ãã·ã³ïŒã¢ãã©ãã€ã·ã³ 25ïŒ50ïŒ0.8ïŒ25ïŒïŒïŒ 12.5ïŒ50ïŒ6.25ïŒ25ïŒïŒïŒ 6.25ïŒ50ïŒ12.5ïŒ25ïŒïŒïŒ äžèšã®æçç©è³ªåå€ã奜ãŸããçµåãã§ããã ã¿ã€ãã·ã³âããã©ãã€ã·ã³ ã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³ ã¿ã€ãã·ã³âã²ã³ã¿ãã€ã·ã³ ãã€ã³ãã€ã·ã³âããã©ãã€ã·ã³ ã¹ãããã€ã·ã³âããã©ãã€ã·ã³ ãã°ããã€ã·ã³âããã©ãã€ã·ã³ ç¹ã«å¥œãŸããçµåãã¯ãã¿ã€ãã·ã³âããã©ã
ã€ã·ã³ãã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³ããã³ã¿ã€
ãã·ã³âã²ã³ã¿ãã€ã·ã³ã§ããã æ¬çºæã®æçç©è³ªåå€ã¯ãäžè¿°ã®ãšãããçš®ã
ã®åç©çŸç ã®æ²»çäžãåç©çšè¬åãšããŠäŸ¡å€ãã
ãã®ã§ããããŸãããã®åå€ã¯ãçµç¹å¹é€æ³ã«ã
ã€ãŠãŠã€ã«ã¹ãå¢æ®ãããã«éããŠããã€ã³ãã©
ãºãæ±æãå¶åŸ¡ããããã«ã䟡å€ãããã®ã§ã
ãã 以äžã®å®æœäŸã¯ãæ¬çºæãããã«å ·äœçã«èª¬æ
ãããã®ã§ããã å®æœäŸ ïŒ çµç¹å¹é€çšãã©ã¹ã³äžã§ãïŒïŒ 銬è¡æž ãå«ãå¹
å°199ã«LLCâMK2ïŒç¿è 现èç³»ïŒçŽ°èãæžæ¿ã
ãããã®åïŒmlã«ãïŒæ¥ä»€ã®Mycoplasma
hyorhinisïŒã€ãŒãã³å¹å°ãïŒÃ108åïŒmlïŒãæ¥
çš®ããã现èæžæ¿æ¶²ã®å®¹ç©ã«å¯ŸããŠçŽïŒâïŒïŒ ã®
ãã€ã³ãã©ãºãå¹é€ç©ãçšãããæ¥çš®åŸã现èæž
æ¿æ¶²ã¯ã37âã§ïŒâïŒæ¥éå¹é€ãããã³ã³ãããŒ
ã«å¹å°ãåæ§ã«ããŠèª¿è£œãããå¹é€åŸãã³ã³ãã
ãŒã«å¹é€ç©ããã³ãã€ã³ãã©ãºãå«æå¹é€ç©ã®å¹
å°ããïŒïŒ 銬è¡æž ãš1.68ïœã®éçé žãããªãŠã ã
å«ãæ°é®®ãªå¹å°199ã§çœ®æããã次ã«ããã®å¹é€
ç©ããïŒåœã1..68ïœã®éçé žãããªãŠã ãå«
ãå¹å°199ã«ã¿ã€ãã·ã³ãããã©ãã€ã·ã³ããã³
ã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã溶ããã溶液
ã§åŠçãããåæçç©è³ªããã³åå€ã®æº¶æ¶²ã¯ãæ¿
床1000mcgïŒmlã§èª¿è£œãããåå€ã®æº¶æ¶²ã¯åæç
ç©è³ªã®æ¿åºŠã1000mcgïŒmlãšãªãããã«ãããïŒ
åçšéæ³ã«ããã0.39mcgïŒmlãŸã§ã®çš®ã ã®æ¿åºŠ
ã®æº¶æ¶²ã調補ãããåæçç©è³ªæº¶æ¶²ããçµç¹å¹é€
液ãå«ãå¥ã ã®ãã©ã¹ã³ã«å ããã çµç¹å¹é€å¹å°ã¯ããã©ã¹ã³ããšã«é±ã«ïŒå亀æ
ããå¹å°äº€æã®éœåºŠãïŒé±éã«ããã€ãŠãåäžæ¿
床ã®æ°ããæçç©è³ªæº¶æ¶²ãæ·»å ãããïŒé±éåŸã
æ°é®®å¹å°ã®äº€æã¯ããã«ïŒé±éãæçç©è³ªã®æ·»å
ãè¡ããã«ç¶ãããå¹å°äº€æã®éœåºŠããã®åã«å¹
é€ç©ã®ãµã³ãã«ãæ¡ããå¹é€ããŠãã€ã³ãã©ãºã
ã®ååŠã確ãããåæçç©è³ªã¿ã€ãã·ã³ããã³ã
ãã©ãã€ã·ã³ãªãã³ã«ãã®åå€ã®æå°çºè²é»æ¢æ¿
床ã¯ããµã³ãã«ã«ã€ããŠãã€ã³ãã©ãºãã®å¹é€ã«
æåããªãã€ãçµç¹å¹é€ã«ãããæçç©è³ªã®æäœ
æ¿åºŠãšãããæå°çºè²é»æ¢æ¿åºŠã¯ãã¿ã€ãã·ã³å
ç¬ã§ã¯100mcgïŒmlããããŠããã©ãã€ã·ã³åç¬
ã§ã¯100mcgïŒmlã§ãã€ãã®ã«å¯ŸããŠãåå€ã§ã¯
3mcgïŒmlã§ãã€ãã å®æœäŸ ïŒ ã¿ã€ãã·ã³ãã¢ãã©ãã€ã·ã³ããã³ã¿ã€ãã·ã³
âã¢ãã©ãã€ã·ã³åå€ã«ã€ããŠãå®æœäŸïŒã«èšèŒ
ããæ¹æ³ãšæé ã§M.hyorhinisHHã«ããçµç¹å¹
é€æ±æè©Šéšãè¡ã€ããšãããã¿ã€ãã·ã³åç¬ã§ã¯
MIC200mcgïŒmlãã¢ãã©ãã€ã·ã³åç¬ã§ã¯
MIC600mcgïŒmlãã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³
åå€ã§ã¯MIC12mcgïŒmlã§ãã€ãã å®æœäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ãããŠãM.hyorhinisã䜿çš
ããããã©ãã€ã·ã³ã«ä»£ããŠã²ã³ã¿ãã€ã·ã³ãã
ã¿ã€ãã·ã³âããã©ãã€ã·ã³åå€ã«ä»£ããŠã¿ã€ã
ã·ã³âã²ã³ã¿ãã€ã·ã³åå€ãçšãããšãããã¿ã€
ãã·ã³åç¬ã®MICã¯400mcgïŒmlã§ãã€ãããã
ãŠãã¿ã€ãã·ã³âã²ã³ã¿ãã€ã·ã³åå€ã§ã¯ã
MIC0.78mcgïŒmlã瀺ããã å®æœäŸ ïŒ å®æœäŸïŒã§çšããã¿ã€ãã·ã³âããã©ãã€ã·ã³
åå€ã«ä»£ããŠããã€ã³ãã€ã·ã³âããã©ãã€ã·ã³
åå€ã䜿çšããããã€ã³ãã€ã·ã³åç¬ã§ã¯
MIC400mcgïŒmlããããŠããã©ãã€ã·ã³åç¬ã§
ã¯MIC200mcgïŒmlã§ãã€ãããåå€ã§ã¯
MIC0.78mcgïŒmlã§ãã€ãã å®æœäŸ ïŒ å¹³åäœé6.0Kgã®é¢ä¹³è±96é ããäœéã«ããä»»
æã«ãïŒçèåœãïŒé ãã€12çèã«åããããã
ã«ã次ã®ïŒçš®ã®åŠçœ®ãè¡ã€ããïŒïŒè¬ç©ãæäžã
ãªãã³ã³ãããŒã«ïŒïŒïŒã¢ãã©ãã€ã·ã³110ppm
ã飌æã«æ··å ¥ããŠæåïŒïŒïŒã¿ã€ãã·ã³ãªã³é žå¡©
110ppmã飌æã«æ··å ¥ããŠæåïŒïŒïŒã¢ãã©ãã€
ã·ã³ç¡«é žããã³ã¿ã€ãã·ã³ãªã³é žå¡©ã®äž¡è
110ppmã飌æã«æ··å ¥ããŠæåãååŠçã¯ãïŒç
èã§ã¬ããªã±ãŒãããã è±ã¯ã20ïŒ èçœè³ªã®ããŠã¢ãã³ã·â倧è±é£Œæã«
è¥å¹²ã®æŒãã«ã©ã¹ã ã®ïŒrolled oatsïŒãå ãã
ãã®ãã21æ¥éä»»æã«å«é£ãããã糧é£ã®ãã©ã³
ã¹äžå¿ èŠãªãã¿ãã³é¡ããã³ããã©ã«é¡ãå ã
ãããã¹ãŠã®è±ã®é£Œæã¯ãé©åœãªæçç©è³ªãŸãã¯
æçç©è³ªåå€ãè¬ç©æ·»å åºã§å ããç¹ã ãã§ç°ã€
ãŠããããã¹ãŠã®é£Œæã¯å«é£åã«æ€éããæ€éæ
éã®çµç¹ã§æ®å飌æãæ€éããå»æ£ãããè±ã®äœ
éã¯ãè©Šéšéå§æããã³ãã®åŸé±ããšã«æ€éã
ãã äžç¢è©ç¹ã¯çèåäœã§è¡ã€ããè©ç¹ã¯ãåäžäºº
ãåãã®13æ¥éã¯ïŒæ¥ïŒåã®ã¹ã±ãžãŠãŒã«ã§ã14
æ¥ç®ã¯ïŒåå®æœãããè©ç¹ææšã¯ãè¡šïŒã®èš»ïŒïŒ
ã«ç€ºãããã®ãšåããšããã çªå€ã®ïŒçèã®è±ã¯çŽ°èåŠç調æ»çšãšãããã
ããã®è±ã¯ãåçèãžã®é ååŸã«äžç¢ãèµ·ããæ
ç¹ã§ãè¬ç©æ·»å 飌æãäžããããšãªãåæ€ããã åäºæè žãŸãã¯åè žå 容ç©ïŒmlåœãã®ããŒã¿ãŒ
溶è¡æ§å€§è žèïŒbeta hemolytic E.coliïŒã®æ°ãã
åæ€ããåç©ã§èšæž¬ããããã®çµæãæ€å®ããïŒ
é ã®è±ã®åäºæè žäžã«107ããã³108åã®å€§è žèã®
ååšã蚌æããããµã«ã¢ãã©ã®å¹é€è©Šéšã®çµæã¯
é°æ§ã§ãã€ãã ãã®è©Šéšçµæã¯ãäœéå¢å ãäžç¢é »åºŠã®äœæžã
ãã³é£Œæå¹çã®æ¹åã®åé ç®ã«ã€ããŠè¡šïŒããã³
ïŒã«ç€ºãããŠããã
è©ç¹ãæéïŒæ¥ïŒã«å¯ŸããŠããããããã°ã©ãã§
ãããããããã¯ãã³ã³ãããŒã«çŸ€ããã³ååŠçœ®
矀ã®å¹³åè©ç¹ã§è¡ã€ããã¿ã€ãã·ã³âã¢ãã©ãã€
ã·ã³åå€åŠçœ®çŸ€ã®å¹³åè©ç¹ããããã瀺ããŠãã
ããã«ãäžç¢é »åºŠã¯ã¢ãã©ãã€ã·ã³åç¬åŠçœ®çŸ€ã§
ã®é »åºŠããèããäœãã€ãããã®ã°ã©ãã¯ãŸãã
ã¿ã€ãã·ã³åç¬ã§ãäžç¢é »åºŠã®äœæžã«ããçšåºŠæ
å¹ã§ããããšã瀺ããŠããã æ¬çºæã®æ¹æ³ãå®æœããã«ã¯ãè±ãé¢ä¹³æãã
é¢ä¹³åŸïŒâïŒé±éæ¬æçç©è³ªåå€ã§åŠçœ®ãããç
ç¶ãé節ã§ãããšãã¯ãå¿ èŠã«å¿ããŠããã«é·æ
æ²»çããããšãã§ããã åèšè¡šïŒã«è¡šç€ºããæ°å€ã¯ãåŠçœ®çŸ€ãšã³ã³ãã
ãŒã«çŸ€ãšã®éã®äžç¢é »åºŠã®çžéããã³ã³ãããŒã«
矀ã«å¯ŸããçŸåçã§ç€ºããŠããã æ¬çºæã®ã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã¯ã
ãã¹ããŠã¬ã©ã»ãã¢ãªãã€ã«ã®æ ªïŒPasteurella
hemolytica strainsïŒã«å¯ŸããŠçžä¹ç掻æ§ãæã
ãããã®åŸ®çç©ã¯çã®èºçãèµ·ããé節ãªææã¯
æ»ã«è³ãããããã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³å
å€ã®çžä¹å¹æã¯ãP.hemolytica41Dæ ªã«å¯Ÿããin
vitroè©Šéšã§èšŒæããããã¿ã€ãã·ã³åç¬ã®æå°
çºè²é»æ¢æ¿åºŠã¯50mcgïŒmlã§ãããã¢ãã©ãã€ã·
ã³åç¬ã®ããã¯25mcgïŒmlã§ãã€ããäºã€ã®æç
ç©è³ªã®åå€ã®çžä¹ç掻æ§ã¯ãæè¬âããšãã«ãŒã
ãŒãâ滎å®æ³ã«ãã€ãŠèšŒæãããããã®æ¹æ³ã§
ã¯ãäºã€ã®æçç©è³ªãšé 次çšéããåçšé床ããš
ã«ãããã«åçšé床ã®ãã¹ãŠã®çµåãã«ã€ããŠæ€
å®ãè¡ã€ãŠã被éšã®çè²ãé»æ¢ããæ¿åºŠããåæ
çç©è³ªåç¬ããã³äž¡è ã®çµåãã«ã€ããŠæ±ããã
äž¡æçç©è³ªã®çžäºäœçšã¯ã代æ°åŠçãŸãã¯å¹ŸäœåŠ
çã«æ±ºå®ããåŸãã代æ°åŠçææ³ã§ã¯ãçè²ãé»
æ¢ããçµåãã«ãããåæçç©è³ªã®æ¿åºŠãããã®
æçç©è³ªãåç¬ã§äœ¿çšããŠåäžã®å¹æãåŸããšã
ã®æ¿åºŠãšã®æ¯ã§æ±ããããã®æ¯ã®åèšãïŒã§ãã
ã°ãã®çµåãã¯çžå çã§ããããã®åèšãïŒãã
å°ãããã°ãã®çµåãã¯çžä¹çã§ããããããŠã
ã®åèšãïŒãã倧ãããã°ãã®çµåãã¯æ®æçã§
ããããšã«ãªãã ã¿ã€ãã·ã³ãã¢ãã©ãã€ã·ã³ããã³äž¡è ã®çµå
ãã®P.hemolyticaã«å¯Ÿããin vitroè©Šéšã§åŸãæ°
å€ãçšããèšç®çµæã以äžã«ç€ºãã ã¿ã€ãã·ã³åç¬MICïŒ50mcgïŒml ã¢ãã©ãã€ã·ã³åç¬MICïŒ25mcgïŒml ã¿ã€ãã·ã³ïŒã¢ãã©ãã€ã·ã³ 25ïŒ50ïŒ0.8ïŒ25ïŒïŒïŒ 12.5ïŒ50ïŒ6.25ïŒ25ïŒïŒïŒ 6.25ïŒ50ïŒ12.5ïŒ25ïŒïŒïŒ äžèšã®æçç©è³ªåå€ã奜ãŸããçµåãã§ããã ã¿ã€ãã·ã³âããã©ãã€ã·ã³ ã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³ ã¿ã€ãã·ã³âã²ã³ã¿ãã€ã·ã³ ãã€ã³ãã€ã·ã³âããã©ãã€ã·ã³ ã¹ãããã€ã·ã³âããã©ãã€ã·ã³ ãã°ããã€ã·ã³âããã©ãã€ã·ã³ ç¹ã«å¥œãŸããçµåãã¯ãã¿ã€ãã·ã³âããã©ã
ã€ã·ã³ãã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³ããã³ã¿ã€
ãã·ã³âã²ã³ã¿ãã€ã·ã³ã§ããã æ¬çºæã®æçç©è³ªåå€ã¯ãäžè¿°ã®ãšãããçš®ã
ã®åç©çŸç ã®æ²»çäžãåç©çšè¬åãšããŠäŸ¡å€ãã
ãã®ã§ããããŸãããã®åå€ã¯ãçµç¹å¹é€æ³ã«ã
ã€ãŠãŠã€ã«ã¹ãå¢æ®ãããã«éããŠããã€ã³ãã©
ãºãæ±æãå¶åŸ¡ããããã«ã䟡å€ãããã®ã§ã
ãã 以äžã®å®æœäŸã¯ãæ¬çºæãããã«å ·äœçã«èª¬æ
ãããã®ã§ããã å®æœäŸ ïŒ çµç¹å¹é€çšãã©ã¹ã³äžã§ãïŒïŒ 銬è¡æž ãå«ãå¹
å°199ã«LLCâMK2ïŒç¿è 现èç³»ïŒçŽ°èãæžæ¿ã
ãããã®åïŒmlã«ãïŒæ¥ä»€ã®Mycoplasma
hyorhinisïŒã€ãŒãã³å¹å°ãïŒÃ108åïŒmlïŒãæ¥
çš®ããã现èæžæ¿æ¶²ã®å®¹ç©ã«å¯ŸããŠçŽïŒâïŒïŒ ã®
ãã€ã³ãã©ãºãå¹é€ç©ãçšãããæ¥çš®åŸã现èæž
æ¿æ¶²ã¯ã37âã§ïŒâïŒæ¥éå¹é€ãããã³ã³ãããŒ
ã«å¹å°ãåæ§ã«ããŠèª¿è£œãããå¹é€åŸãã³ã³ãã
ãŒã«å¹é€ç©ããã³ãã€ã³ãã©ãºãå«æå¹é€ç©ã®å¹
å°ããïŒïŒ 銬è¡æž ãš1.68ïœã®éçé žãããªãŠã ã
å«ãæ°é®®ãªå¹å°199ã§çœ®æããã次ã«ããã®å¹é€
ç©ããïŒåœã1..68ïœã®éçé žãããªãŠã ãå«
ãå¹å°199ã«ã¿ã€ãã·ã³ãããã©ãã€ã·ã³ããã³
ã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã溶ããã溶液
ã§åŠçãããåæçç©è³ªããã³åå€ã®æº¶æ¶²ã¯ãæ¿
床1000mcgïŒmlã§èª¿è£œãããåå€ã®æº¶æ¶²ã¯åæç
ç©è³ªã®æ¿åºŠã1000mcgïŒmlãšãªãããã«ãããïŒ
åçšéæ³ã«ããã0.39mcgïŒmlãŸã§ã®çš®ã ã®æ¿åºŠ
ã®æº¶æ¶²ã調補ãããåæçç©è³ªæº¶æ¶²ããçµç¹å¹é€
液ãå«ãå¥ã ã®ãã©ã¹ã³ã«å ããã çµç¹å¹é€å¹å°ã¯ããã©ã¹ã³ããšã«é±ã«ïŒå亀æ
ããå¹å°äº€æã®éœåºŠãïŒé±éã«ããã€ãŠãåäžæ¿
床ã®æ°ããæçç©è³ªæº¶æ¶²ãæ·»å ãããïŒé±éåŸã
æ°é®®å¹å°ã®äº€æã¯ããã«ïŒé±éãæçç©è³ªã®æ·»å
ãè¡ããã«ç¶ãããå¹å°äº€æã®éœåºŠããã®åã«å¹
é€ç©ã®ãµã³ãã«ãæ¡ããå¹é€ããŠãã€ã³ãã©ãºã
ã®ååŠã確ãããåæçç©è³ªã¿ã€ãã·ã³ããã³ã
ãã©ãã€ã·ã³ãªãã³ã«ãã®åå€ã®æå°çºè²é»æ¢æ¿
床ã¯ããµã³ãã«ã«ã€ããŠãã€ã³ãã©ãºãã®å¹é€ã«
æåããªãã€ãçµç¹å¹é€ã«ãããæçç©è³ªã®æäœ
æ¿åºŠãšãããæå°çºè²é»æ¢æ¿åºŠã¯ãã¿ã€ãã·ã³å
ç¬ã§ã¯100mcgïŒmlããããŠããã©ãã€ã·ã³åç¬
ã§ã¯100mcgïŒmlã§ãã€ãã®ã«å¯ŸããŠãåå€ã§ã¯
3mcgïŒmlã§ãã€ãã å®æœäŸ ïŒ ã¿ã€ãã·ã³ãã¢ãã©ãã€ã·ã³ããã³ã¿ã€ãã·ã³
âã¢ãã©ãã€ã·ã³åå€ã«ã€ããŠãå®æœäŸïŒã«èšèŒ
ããæ¹æ³ãšæé ã§M.hyorhinisHHã«ããçµç¹å¹
é€æ±æè©Šéšãè¡ã€ããšãããã¿ã€ãã·ã³åç¬ã§ã¯
MIC200mcgïŒmlãã¢ãã©ãã€ã·ã³åç¬ã§ã¯
MIC600mcgïŒmlãã¿ã€ãã·ã³âã¢ãã©ãã€ã·ã³
åå€ã§ã¯MIC12mcgïŒmlã§ãã€ãã å®æœäŸ ïŒ å®æœäŸïŒã®æ¹æ³ã«ãããŠãM.hyorhinisã䜿çš
ããããã©ãã€ã·ã³ã«ä»£ããŠã²ã³ã¿ãã€ã·ã³ãã
ã¿ã€ãã·ã³âããã©ãã€ã·ã³åå€ã«ä»£ããŠã¿ã€ã
ã·ã³âã²ã³ã¿ãã€ã·ã³åå€ãçšãããšãããã¿ã€
ãã·ã³åç¬ã®MICã¯400mcgïŒmlã§ãã€ãããã
ãŠãã¿ã€ãã·ã³âã²ã³ã¿ãã€ã·ã³åå€ã§ã¯ã
MIC0.78mcgïŒmlã瀺ããã å®æœäŸ ïŒ å®æœäŸïŒã§çšããã¿ã€ãã·ã³âããã©ãã€ã·ã³
åå€ã«ä»£ããŠããã€ã³ãã€ã·ã³âããã©ãã€ã·ã³
åå€ã䜿çšããããã€ã³ãã€ã·ã³åç¬ã§ã¯
MIC400mcgïŒmlããããŠããã©ãã€ã·ã³åç¬ã§
ã¯MIC200mcgïŒmlã§ãã€ãããåå€ã§ã¯
MIC0.78mcgïŒmlã§ãã€ãã å®æœäŸ ïŒ å¹³åäœé6.0Kgã®é¢ä¹³è±96é ããäœéã«ããä»»
æã«ãïŒçèåœãïŒé ãã€12çèã«åããããã
ã«ã次ã®ïŒçš®ã®åŠçœ®ãè¡ã€ããïŒïŒè¬ç©ãæäžã
ãªãã³ã³ãããŒã«ïŒïŒïŒã¢ãã©ãã€ã·ã³110ppm
ã飌æã«æ··å ¥ããŠæåïŒïŒïŒã¿ã€ãã·ã³ãªã³é žå¡©
110ppmã飌æã«æ··å ¥ããŠæåïŒïŒïŒã¢ãã©ãã€
ã·ã³ç¡«é žããã³ã¿ã€ãã·ã³ãªã³é žå¡©ã®äž¡è
110ppmã飌æã«æ··å ¥ããŠæåãååŠçã¯ãïŒç
èã§ã¬ããªã±ãŒãããã è±ã¯ã20ïŒ èçœè³ªã®ããŠã¢ãã³ã·â倧è±é£Œæã«
è¥å¹²ã®æŒãã«ã©ã¹ã ã®ïŒrolled oatsïŒãå ãã
ãã®ãã21æ¥éä»»æã«å«é£ãããã糧é£ã®ãã©ã³
ã¹äžå¿ èŠãªãã¿ãã³é¡ããã³ããã©ã«é¡ãå ã
ãããã¹ãŠã®è±ã®é£Œæã¯ãé©åœãªæçç©è³ªãŸãã¯
æçç©è³ªåå€ãè¬ç©æ·»å åºã§å ããç¹ã ãã§ç°ã€
ãŠããããã¹ãŠã®é£Œæã¯å«é£åã«æ€éããæ€éæ
éã®çµç¹ã§æ®å飌æãæ€éããå»æ£ãããè±ã®äœ
éã¯ãè©Šéšéå§æããã³ãã®åŸé±ããšã«æ€éã
ãã äžç¢è©ç¹ã¯çèåäœã§è¡ã€ããè©ç¹ã¯ãåäžäºº
ãåãã®13æ¥éã¯ïŒæ¥ïŒåã®ã¹ã±ãžãŠãŒã«ã§ã14
æ¥ç®ã¯ïŒåå®æœãããè©ç¹ææšã¯ãè¡šïŒã®èš»ïŒïŒ
ã«ç€ºãããã®ãšåããšããã çªå€ã®ïŒçèã®è±ã¯çŽ°èåŠç調æ»çšãšãããã
ããã®è±ã¯ãåçèãžã®é ååŸã«äžç¢ãèµ·ããæ
ç¹ã§ãè¬ç©æ·»å 飌æãäžããããšãªãåæ€ããã åäºæè žãŸãã¯åè žå 容ç©ïŒmlåœãã®ããŒã¿ãŒ
溶è¡æ§å€§è žèïŒbeta hemolytic E.coliïŒã®æ°ãã
åæ€ããåç©ã§èšæž¬ããããã®çµæãæ€å®ããïŒ
é ã®è±ã®åäºæè žäžã«107ããã³108åã®å€§è žèã®
ååšã蚌æããããµã«ã¢ãã©ã®å¹é€è©Šéšã®çµæã¯
é°æ§ã§ãã€ãã ãã®è©Šéšçµæã¯ãäœéå¢å ãäžç¢é »åºŠã®äœæžã
ãã³é£Œæå¹çã®æ¹åã®åé ç®ã«ã€ããŠè¡šïŒããã³
ïŒã«ç€ºãããŠããã
å³é¢ã¯ãã¢ãã©ãã€ã·ã³ãã¿ã€ãã·ã³ããã³ã¿
ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®è±äžç¢çã«å¯Ÿã
ãå¹æã瀺ãã°ã©ãã§ããã
ã€ãã·ã³âã¢ãã©ãã€ã·ã³åå€ã®è±äžç¢çã«å¯Ÿã
ãå¹æã瀺ãã°ã©ãã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ (a) ã¿ã€ãã·ã³ããã€ã³ãã€ã·ã³ããã°ãã
ã€ã·ã³ãã¹ãããã€ã·ã³ããã³ãªã¬ã¢ã³ããã€
ã·ã³ãªãã³ã«ççåŠçã«èš±å®¹ããããããã®å¡©
ãããªã矀ããéžã°ãããã¯ãã©ã€ãæçç©è³ª
ãšã (b) ããã©ãã€ã·ã³ãã¢ãã©ãã€ã·ã³ãããã©ã
ã€ã·ã³å åïŒãã²ã³ã¿ãã€ã·ã³ããã³ããªãã€
ã·ã³ãªãã³ã«ççåŠçã«èš±å®¹ããããããã®å¡©
ãããªã矀ããéžãã°ããã¢ããã°ãªã³ã·ãæ
çç©è³ªãšãå«æããããšãç¹åŸŽãšããæèçµæ
ç©ã ïŒ ãã¯ãã©ã€ãæçç©è³ªãã¿ã€ãã·ã³ãŸãã¯ã
ã®ççåŠçã«èš±å®¹ãããå¡©ã§ããç¹èš±è«æ±ã®ç¯å²
ïŒèšèŒã®æèçµæç©ã ïŒ ã¢ããã°ãªã³ã·ãæçç©è³ªãããã©ãã€ã·ã³
ãŸãã¯ãã®ççåŠçã«èš±å®¹ãããå¡©ã§ããç¹èš±è«
æ±ã®ç¯å²ïŒãŸãã¯ïŒèšèŒã®æèçµæç©ã ïŒ ã¢ããã°ãªã³ã·ãæçç©è³ªãã¢ãã©ãã€ã·ã³
ãŸãã¯ãã®ççåŠçã«èš±å®¹ãããå¡©ã§ããç¹èš±è«
æ±ã®ç¯å²ïŒãŸãã¯ïŒèšèŒã®æèçµæç©ã ïŒ ã¿ã€ãã·ã³ãŸãã¯ãã®ççåŠçã«èš±å®¹ããã
å¡©ãšããã©ãã€ã·ã³ãŸãã¯ãã®ççåŠçã«èš±å®¹ã
ããå¡©ãå«æããç¹èš±è«æ±ã®ç¯å²ïŒèšèŒã®æèçµ
æç©ã ïŒ (a) ã¿ã€ãã·ã³ããã€ã³ãã€ã·ã³ããã°ãã
ã€ã·ã³ãã¹ãããã€ã·ã³ããã³ãªã¬ã¢ã³ããã€
ã·ã³ãªãã³ã«ççåŠçã«èš±å®¹ããããããã®å¡©
ãããªã矀ããéžã°ãããã¯ãã©ã€ãæçç©è³ª
ãšã (b) ããã©ãã€ã·ã³ãã¢ãã©ãã€ã·ã³ãããã©ã
ã€ã·ã³å åïŒãã²ã³ã¿ãã€ã·ã³ããã³ããªãã€
ã·ã³ãªãã³ã«ççåŠçã«èš±å®¹ããããããã®å¡©
ãããªã矀ããéžãã°ããã¢ããã°ãªã³ã·ãæ
çç©è³ªãšãå«æããããšãç¹åŸŽãšããæèçµæ
ç©ãè±ã«æäžããŠè±ã®æé·ãä¿é²ããŸãã¯é£Œæ
æåãæ¹åããæ¹æ³ã ïŒ (a) ã¿ã€ãã·ã³ããã€ã³ãã€ã·ã³ããã°ãã
ã€ã·ã³ãã¹ãããã€ã·ã³ããã³ãªã¬ã¢ã³ããã€
ã·ã³ãªãã³ã«ççåŠçã«èš±å®¹ããããããã®å¡©
ãããªã矀ããéžã°ãããã¯ãã©ã€ãæçç©è³ª
ãšã (b) ããã©ãã€ã·ã³ãã¢ãã©ãã€ã·ã³ãããã©ã
ã€ã·ã³å åïŒãã²ã³ã¿ãã€ã·ã³ããã³ããªãã€
ã·ã³ãªãã³ã«ççåŠçã«èš±å®¹ããããããã®å¡©
ãããªã矀ããéžãã°ããã¢ããã°ãªã³ã·ãæ
çç©è³ªãšãå«æããããšãç¹åŸŽãšããæèçµæ
ç©ãåºä¹³åç©ã®çµç¹å¹é€å¹å°ã«æ·»å ããŠãã€ã³
ãã©ãºãã®çè²ãæå¶ããæ¹æ³ã ïŒ (a) ã¿ã€ãã·ã³ããã€ã³ãã€ã·ã³ããã°ãã
ã€ã·ã³ãã¹ãããã€ã·ã³ããã³ãªã¬ã¢ã³ããã€
ã·ã³ãªãã³ã«ççåŠçã«èš±å®¹ããããããã®å¡©
ãããªã矀ããéžã°ãããã¯ãã©ã€ãæçç©è³ª
ãšã (b) ããã©ãã€ã·ã³ãã¢ãã©ãã€ã·ã³ãããã©ã
ã€ã·ã³å åïŒãã²ã³ã¿ãã€ã·ã³ããã³ããªãã€
ã·ã³ãªãã³ã«ççåŠçã«èš±å®¹ããããããã®å¡©
ãããªã矀ããéžãã°ããã¢ããã°ãªã³ã·ãæ
çç©è³ªãšãå«æããããšãç¹åŸŽãšããæèçµæ
ç©ãè±ã«æäžããŠè±ã®å€§è žèçãæ²»çããæ¹
æ³ã ïŒ æèçµæç©ãã¿ã€ãã·ã³ãŸãã¯ãã®ççåŠç
ã«èš±å®¹ãããå¡©ãšã¢ãã©ãã€ã·ã³ãŸãã¯ãã®çç
åŠçã«èš±å®¹ãããå¡©ãå«æãããã®ã§ããç¹èš±è«
æ±ã®ç¯å²ïŒèšèŒã®æ¹æ³ã ïŒïŒ æèçµæç©ãã¿ã€ãã·ã³ãªã³é žå¡©ãšã¢ãã©
ãã€ã·ã³ç¡«é žå¡©ãå«æãããã®ã§ããç¹èš±è«æ±ã®
ç¯å²ïŒèšèŒã®æ¹æ³ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10723979A | 1979-12-26 | 1979-12-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5699417A JPS5699417A (en) | 1981-08-10 |
| JPH0141609B2 true JPH0141609B2 (ja) | 1989-09-06 |
Family
ID=22315603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18367180A Granted JPS5699417A (en) | 1979-12-26 | 1980-12-23 | Antibiotic blend |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS5699417A (ja) |
| BE (1) | BE886765A (ja) |
| CA (1) | CA1160569A (ja) |
| PH (1) | PH16876A (ja) |
| ZA (1) | ZA808001B (ja) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009501023A (ja) * | 2005-07-14 | 2009-01-15 | ããªã ãã«ãºïŒ ãšã«ãšã«ã·ãŒ | ã²ã«ããŒã¹ã®å®¶ççšé£Œæã補é æ¹æ³ããã³äœ¿çš |
| JP2012130355A (ja) * | 2012-04-05 | 2012-07-12 | Purina Mills Llc | ã²ã«ããŒã¹ã®å®¶ççšé£Œæã補é æ¹æ³ããã³äœ¿çš |
| US9918487B2 (en) | 2003-12-02 | 2018-03-20 | Purina Mills, Llc | Gel based livestock feed, method of manufacture and use |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201013207D0 (en) * | 2010-08-05 | 2010-09-22 | Helperby Therapeutics Ltd | Novel combination |
-
1980
- 1980-12-19 BE BE1/10083A patent/BE886765A/fr not_active IP Right Cessation
- 1980-12-22 ZA ZA00808001A patent/ZA808001B/xx unknown
- 1980-12-22 CA CA000367383A patent/CA1160569A/en not_active Expired
- 1980-12-23 JP JP18367180A patent/JPS5699417A/ja active Granted
- 1980-12-23 PH PH25029A patent/PH16876A/en unknown
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9918487B2 (en) | 2003-12-02 | 2018-03-20 | Purina Mills, Llc | Gel based livestock feed, method of manufacture and use |
| US10085466B2 (en) | 2003-12-02 | 2018-10-02 | Purina Mills, Llc | Gel based livestock feed, method of manufacture and use |
| US10231473B2 (en) | 2003-12-02 | 2019-03-19 | Purina Mills, Llc | Gel based livestock feed, method of manufacture and use |
| US10383346B2 (en) | 2003-12-02 | 2019-08-20 | Purina Mills, Llc | Gel based livestock feed, method of manufacture and use |
| US10653167B2 (en) | 2003-12-02 | 2020-05-19 | Purina Mills Llc | Gel based livestock feed, method of manufacture and use |
| US11051533B2 (en) | 2003-12-02 | 2021-07-06 | Purina Mills, Llc | Gel based livestock feed, method of manufacture and use |
| JP2009501023A (ja) * | 2005-07-14 | 2009-01-15 | ããªã ãã«ãºïŒ ãšã«ãšã«ã·ãŒ | ã²ã«ããŒã¹ã®å®¶ççšé£Œæã補é æ¹æ³ããã³äœ¿çš |
| JP2012130355A (ja) * | 2012-04-05 | 2012-07-12 | Purina Mills Llc | ã²ã«ããŒã¹ã®å®¶ççšé£Œæã補é æ¹æ³ããã³äœ¿çš |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5699417A (en) | 1981-08-10 |
| ZA808001B (en) | 1982-07-28 |
| CA1160569A (en) | 1984-01-17 |
| PH16876A (en) | 1984-04-02 |
| BE886765A (fr) | 1981-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008297316A (ja) | ãã¿åã³å®¶çŠœé¡ã®çŸæ£åã³ææçã®æ²»çåã³äºé² | |
| RU2197237C2 (ru) | СпПÑПб леÑÐµÐœÐžÑ Ð·Ð°Ð±ÐŸÐ»ÐµÐ²Ð°ÐœÐžÐ¹ жОвПÑÐœÑÑ , вÑзваММÑÑ Ð±Ð°ÐºÑеÑОÑЌО (ваÑОаМÑÑ), О ÑпПÑПб ОзгПÑÐŸÐ²Ð»ÐµÐœÐžÑ Ð»ÐµÐºÐ°ÑÑÑвеММПгП ÑÑеЎÑÑва | |
| EP0032304B1 (en) | Antibiotic compositions | |
| JPH0141609B2 (ja) | ||
| GB2159409A (en) | Synergistic antibiotic composition and process for its preparation | |
| US4379781A (en) | Antibiotic compositions | |
| US20060166905A1 (en) | Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale | |
| US4283388A (en) | Method for treating colibacillosis in pigs with tylosin apramycin compositions | |
| EP0517394B1 (en) | A prophylactic/therapeutic composition for swine pleuropneumonia | |
| KR100516418B1 (ko) | í룚ë¡ë®€ížëŠ°ì ë첎ìììíì ì©ë | |
| US4871722A (en) | Synergistic veterinary composition and/or fodder premix and process for preparing same | |
| EP3838347B1 (en) | Evernimicin for treating diseases like necrotic enteritis | |
| KR950009945B1 (ko) | ìë£ì ëë ë묌ì¬ë£ì 첚ê°ì ë¡ì ê²íë§ìŽì 곌 늰ìœë§ìŽì ì íìì íŒí©ë¬Œì íšì íë ììì ì ë° ìŽì ëŒì§ì¬ì¡ì ëí ì©ë | |
| US3185573A (en) | Animal feed composition and method of using same | |
| KR102199186B1 (ko) | ë³ìì± ìžê· ì ìí ì§ë³ì ìë°© ë° ì¹ë£ì© ììíì ì¡°ì±ë¬Œ | |
| Bletner et al. | Control of Infectious Synovitis: 3. The Efficacy of Chlortetracycline with Relation to Time of Experimental Infection | |
| TW410221B (en) | A pharmaceutical composition for the use in the therapy of a veterinary disease complex caused by increasing stocking density | |
| ISHIMURA et al. | Effects of gentamicin on the intestinal bacterial flora of rats | |
| SE467445B (sv) | Nya laekemedelskompositioner med antimikrobiell aktivitet och foerfarande foer deras framstaellning | |
| Stuart et al. | The Enhancement of Chlortetracycline Activity Against Pasteurella multocida with Sodium Sulfate | |
| KR20220010798A (ko) | ìíëìœê³ íê· ì ë° ìë¯žë žêžëŠ¬ìœìëê³ íê· ì 륌 ì íšì±ë¶ìŒë¡ íšì íë ëë¬Œì© ë³µí©íê· ì ì¡°ì±ë¬Œ | |
| Hare | Antibiotic potentiationâa review | |
| Hoge et al. | The effect of sulfanilamide therapy upon bovine mastitis as indicated by laboratory tests | |
| HU201668B (en) | Method for producing veterinary preparation and fodder premixture of synergetic effect serving for making more economical breeding of animals | |
| JPS61165332A (ja) | 家çãã€ã³ãã©ãºãçãšè±èµ€ç¢ã®äºé²ãŸãã¯æ²»çå€ |